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Synopsis of Secretory Pathway. 
 
The movement of newly synthesized proteins from the site of synthesis to their 
final cellular or extracellular destinations involves transport through a distinct 
series of vesicular compartments. Vesicle biogenesis is regulated by specific 
proteins and co-factors that control distinct steps including budding, transport, 
docking, and fusion with target membranes. 
Budding requires assembly of a coat protein complex on the membrane, 
membrane deformation and the subsequent cleavage of the nascent vesicle 
from donor membrane. 
Three main classes of coats have been identified:  
1) Clathrin participates in endocytosis, lysosome biogenesis and in vesicular 
transport processes, yet uncharacterized, that arise from the trans-Golgi 
network (TGN).  
2) COPI coatomer is involved in retrograde traffic within the Golgi and from 
the cis-Golgi region or the intermediate compartment (ERGIC) to the 
endoplasmic reticulum (ER). 
3) COPII coats is required for budding from the ER.  
 
In order to understand the role of the cytoplasmic coats for the intracellular 
transport of soluble or transmembrane proteins, it is important to characterize 
in more details their contribution along the secretory pathway from the site of 
proteins sinthesis. COPII proteins participate in cargo selection and concentrate 
some proteins in the budding vesicle at specific sites, called ER exit sites 
(ERESs). In mammalian cells ERESs are organized and defined by Sec-16 
(Watson P.	   et	   al.	   2006). Vesicle budding is followed by formation of 
vesicular–tubular transport carriers (VTC) (Aridor M. et al. 1995). The central 
role of COPII in these processes is underlined by studies showing that several 
human disease may result from mutations that affect proteins in COPII vesicles 
(Fred S. et al. 2001,  Fath S. et al. 2007).	  The first step in the assembly of the 
COPII coat is the activation of the small GTPase Sar1 through its guanine 
exchange factor Sec12. The GDP/GTP exchange leads to the exposure of an N-
terminal amphipathic helix of Sar1with consequent insertion into the ER 
membrane (Bi X. Et al. 2002, Bielli A. et al. 2005). This insertion causes 
membrane deformation and is ultimately required for membrane fission (Bielli 
A. et al. 2005, Lee M.C. et al. 2005). Through direct interaction with Sec23, 
Sar1 recruits the heterodimer Sec23–Sec24. The majority of cargoes are 
captured through interaction with Sec24, which exhibits multiple independent 
cargo binding sites (Mossessova E. et al. 2003, Miller E.A. et al. 2003). After 
the incorporation of cargo and the formation of a stable pre-budding complex, 
the outer layer of the coat is recruited to the ER membrane. This outer layer is 
composed of the heterotetramer Sec13–Sec31, which consists of two Sec13 
and two Sec31 subunits (Lederkremer G.Z. et al. 2001, Stagg M.S. et al. 
2006).  
Soon after budding, COPII vesicles uncoat due to the GTP hydrolysis by Sar1 
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(Oka T. et al. 1994). The intrinsic slow rate of Sar1 GTP hydrolysis is 
accelerated in two steps: i. interaction with Sec23 acting as GTPase-activating 
protein for Sar1; ii. binding of Sec13–Sec31 to the pre-budding complex, 
which increases Sec23-mediated GAP activity by an order of magnitude, 
presumably by optimising the interaction of Sec23 with Sar1 (Bielli A. et al. 
2005). Sar1, Sec23–Sec24, and Sec13–Sec31 are the minimal machinery 
required to reconstitute COPII-dependent budding in vitro that is increased by 
the addition of Sec12. In vivo, several other factors are likely to play key roles 
(Fred S. et al. 2003, Yan S.O. et al 2010). For example p125A, originally 
identified as a Sec23A-interacting protein, interacts with the C-terminal region 
of Sec31A and is part of the Sec13/ Sec31A sub-complex and facilitates ER 
export in mammalian cells (Yan S.O. et al 2010). Incorporation of some cargo 
proteins in COPII vesicles is regulated by specific factors. Collagene VII, that 
is too big to fit into normal COPII vesicles (70nm diameter), requires the 
interaction with TANGO1 protein that delays vesicle budding in order to allow 
the entry of the protein into the much larger vesicular carrier (Saito K. Et al. 
2009). In addition, it has been demonstrated that cTAGE5, an integral 
membrane protein containing two coiled-coil motifs and a proline-rich domain, 
is specifically located at the ER exit sites and acts as TANGO1 co-receptor 
important for the ER export of Collagene VII (Kota S. et al. 2011). 
The first station for soluble and transmembrane proteins exiting from the ER is 
the ERGIC. The principal marker for this compartment is the type I 
transmembrane protein ERGIC-53, a mannose-binding lectin required for the 
export of several cargoes from the ER (Appenzeller C. et al. 1999, Nichols 
W.C. et al. 1998) as well as for maintaining the structural integrity of ERGIC  
(Nichols W.C. et al. 1998). Mutations in the ERGIC-53 gene cause autosomal 
recessive bleeding disorders resulting from the inability to package the blood 
clotting factors V and VIII (Nichols W.C. et al. 1998). ERGIC-53 interacts 
directly with Sec23 leading to the recruitment of ERGIC-53/cargo complexes 
into COPII vesicles. After reaching the ERGIC, the cargo dissociates from the 
complex and ERGIC-53 is recycled back to the ER (Kappler F. et al. 1997). 
Retrograde transport is mediated by COPI vesicles. COPI was originally 
discovered through an in vitro reconstitution system that sought to study 
vesicular transport among the Golgi stacks. The initial structure identified was 
a seven-subunit (α, β, β', γ, δ, ε, ζ) complex named coatomer (Beck R. et al. 
2009). The process of COPI vesicle biogenesis is controlled by Arf1, a small 
GTPase of the Ras superfamily. A guanine nucleotide exchange factor (GEF) 
containing a Sec7 domain induces the exchange of bound GDP to GTP in Arf1. 
GBF1, a large Sec7 domain-containing GEF is the major exchange factor 
involved in COPI vesicle biogenesis. Following nucleotide exchange, Arf1 
undergoes a conformational change, leading to the exposure of a myristoylated 
N-terminal amphipathic helix that provides stable membrane anchorage and 
leads to the membrane deformation and recruits the others proteins of the COPI 
machinery (Beck R. et al. 2009). 
The next compartment along the secretory pathway is the Golgi complex. This 
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apparatus is a labyrinth of cisternal membranes constituting the main transport 
pathway for secretory proteins between the ER and the plasma membrane. It is 
well established that glycoproteins, glycolipids and proteoglycans in transit 
through the Golgi system encounter modification by a large number of 
glycosyltransferases, sulfotransferases, proteases and other classes of enzymes 
(Kristian Prydz et al. 2008). 
Two main models have been preposed to describe the movement of cargo 
proteins and lipids through the golgi-cisternae are principally two: “The 
anterograde vesicular trafficking model” and “The cisternal-maturation 
model”. In the first model, it was postulated that coatomer-coated vesicles 
carried cargo forwards from one compartment to the next. This simple and 
straightforward model has received considerable support for the first 
trafficking step of the secretory pathway, from the ER to the first post-ER 
compartment, which is mediated by the COPII coat. 
In the second model, cargo that entry in the cis-Golgi will remain there for a 
fixed amount of time while glycosylation enzymes are delivered sequentially 
via retrograde trafficking to the compartment in which the cargo molecules are 
located. 
Recently, it has been proposed an other model, “The rapid-partitioning model”, 
that is principally based on three key elements: sorting of lipids into different 
domains at each level of the Golgi; bidirectional trafficking of cargo and 
processing enzymes within the Golgi; and association of proteins with their 
preferred lipid environment. In addition to the standard trafficking pathways of 
cargo and glycosylation enzymes between ER and Golgi, the model postulates 
the trafficking of resident Golgi enzymes and cargo in both directions through 
the Golgi. This bidirectional trafficking is at variance from the cisternal-
maturation model, which assumes retrograde trafficking of only glycosylation 
enzymes (Catherine L. Jackson et al. 2009). 
Finally, macromolecules traversing the Golgi complex exit from this organelle 
in vesicular or tubular structures, rising from the trans Golgi Network (TGN), 
destined for different cellular target membranes. This process is principally 
based on the recognition of specific sorting motifs in the cytosolic tail of 
transmembrane cargo and cargo receptors by cytosolic adaptors and coat 
proteins. The key components of these machineries include small GTPases of 
the ARF and Rab family adaptors, GRIP-golgins and lipids, such as 
phosphoinositides, sphingolipids and cholesterol. Once activated by specific 
nucleotide exchange factors, ARF1 promotes the recruitment of cytosolic 
protein complexes that recognize the cargo sorting motifs and bind to clathrin, 
thus functioning as adaptors between cargo proteins and clathrin coat. These 
coat adaptors include the AP1A and AP3 complexes and the GGAs, which 
mediate endosomal sorting (Robinson M. S. et al. 2004). 	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1.1.1 Abstract. 
 
E3 ubiquitin ligases give specificity to the ubiquitylation process by selectively 
binding substrates. Recently, their function has emerged as a crucial modulator 
of T-cell tolerance and immunity. However, substrates, partners and 
mechanism of action for most E3 ligases remain largely unknown. 
In this study, we identified the human T-cell co-receptor CD8 a-chain as 
binding partner of the ligand of Numb proteins X1 (LNX1p80 isoform) and X2 
(LNX2). Both LNX mRNAs were found expressed in T cells purified from 
human blood, and both proteins interacted with CD8a in human HPB-ALL T 
cells. By using an in vitro assay and a heterologous expression system we 
showed that the interaction is mediated by the PDZ (PSD95-DlgA-ZO-1) 
domains of LNX proteins and the cytosolic C-terminal valine motif of CD8a. 
Moreover, CD8a redistributed LNX1 or LNX2 from the cytosol to the plasma 
membrane, whereas, remarkably, LNX1 or LNX2 promoted CD8a 
ubiquitylation, downregulation from the plasma membrane, transport to the 
lysosomes, and degradation. 
Our findings highlight the function of LNX proteins as E3 ligases and suggest 
a mechanism of regulation for CD8a localization at the plasma membrane by 
ubiquitylation and endocytosis. 
CHAPTER	  I	  
Regulation of receptor level on plasma membrane	  
1.1.2	  	  
	   5	  
1.1.2 Regulation of receptor level on plasma membrane. 	  
Endocytosis is the process by which an intracellular vesicle is formed by 
membrane invagination, engulfing extracellular and membrane-bound 
components. Endocytosis and the opposite process of exocytosis are required 
for a large number of essential cell functions, including nutrient uptake, cell-
cell communication, and the turn-over of the plasma membrane composition. 
The central role of these transport mechanisms is well appreciated in receptor 
regulation, neurotransmission, and drug delivery (Oved S. et al. 2002; Schmidt 
AA. 2002). In addition, it has been demostrated that endocytosis plays an  
important role in the signaling: several receptors signal mostly in the 
intracellular membrane, after activation by the ligand and internalization, or 
signal differently from intracellular membrane and from the cell surface 
(Amandio V. Vieira et al. 1996; Harald W Platta and Harald Stenmark 2011; 
Fumiko Itoh et al. 2002; Di Guglielmo M.G. et al. 2003). Endocytosis exists 
in different forms: phagocytosis, pinocytosis, receptor-mediated endocytosis. 
Other mechanisms include caveolae-mediated endocytosis and transient 
poration induced by the cellular microenvironment (Parton RG. et al. 2003). 
The uptake of material inside the cell was first visualized following the 
introduction of glutaraldehyde fixation in the 1960s; this generated electron 
microscopy images of vesicles with proteinaceous coats in many different tis-
sues (Rosenbluth J. et al. 1964; Roth T.F. et al. 1964). Clathrin was then 
identified as being the major protein making the lattice-like coat around 
vesicles, which were described as “vesicles in a basket”.  
Clathrin-mediated endocytosis is the uptake of material into the cell from the 
surface using clathrin-coated vesicles. Although clathrin-coated vesicles can 
also be formed from other membranous compartments, the term clathrin-
mediated endocytosis is used to refer only to intake through vesicles formed 
from the plasma membrane. The pathway is versatile, as many different 
cargoes can be packaged using a range of accessory adaptor proteins. Clathrin-
mediated endocytosis is used by all known eukaryotic cells. Other clathrin-
independent entry portals (such as caveolin-dependent pathways) have been 
described, although their molecular details and cargo specificity are not as well 
defined (Harvey T.M. et al. 2011). 
Clathrin-coated vesicle (CCV) formation proceeds through five stages that 
correspond to ultrastructural and cell biological observations: initiation, cargo 
selection, coat assembly, scission and uncoating. Following cargo selection and 
initiation of pit formation, soluble clathrin polymerize into hexagons and 
pentagons, the relative ratio of which accommodates a wide range of 
membrane curvatures. Clathrin does not bind directly to the membrane or to 
cargo receptors and thus relies on adaptor proteins and complexes (such as 
adaptor protein 2 - AP2) and accessory proteins (such as AP180 and epsin) to 
be recruited to the plasma membrane (Harvey T.M. et al. 2011). Although the 
endocytosis of cargo receptors can be stimulated by ligand binding (for 
example, epidermal growth factor receptor - EGFR), other receptors (for 
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example, transferrin receptor - TfR) are constitutively internalized. When a 
receptor has been taken up, it is sorted in endosomes and either sent back to the 
surface or targeted to more mature endosomes and later compartments (such as 
multivesicular bodies and lysosomes) (Hopkins C.R. et al. 1985). Receptor 
internalization results in the desensitization of the cell toward ligand induced 
signaling.  
Signals for the incorporation of cargo receptors into plasma membrane-derived 
CCV have been defined based on examination of protein sequences. The best 
characterized signal sequence is the YXXØ motif, in which Ø represents a 
bulky hydrophobic amino acid. Such signals are found in both constitutively 
endocytosed receptors (i.e. transferrin receptor) and receptors which are 
endocytosed only after ligand binding (Epidermal Growth Factor - EGF). In 
the latter case, ligand binding causes phosphorylation of the receptor and a 
conformational change that results in the exposure of the internalization signal 
(Madshus I.H., Stang E. 2009). The µ2 adaptin subunit has been shown to 
interact with these tyrosine-based internalization signals (Boll W. et al. 2003). 
An alternative internalization signal, dileucine, does not interact with the µ2 
chain in-vitro, although there is evidence indicating an interaction with AP-2 
(Rahel Byland et al. 2007). An exception to the model of AP-2-mediated 
recruitment of receptors to CCV is provided by G-protein coupled receptors 
where other adaptor proteins, called β-arrestins, are critical for mediating 
endocytosis (Fadi F. Hamdan et al. 2007). Following endocytosis, individual 
receptors can be sorted between recycling and degradative pathways (Tsao P et 
al. 2001; Whistler JL et al. 2002). For a recycling receptor, endocytosis can 
serve as a mechanism for receptor resensitization by delivering internalized 
receptors back to the plasma membrane in a fully active state. Alternatively, 
for receptors that have to be degraded, rapid endocytosis can serve as a first 
step towards receptor down-regulation by delivering the receptors to late 
endosomes and lysosomes. The cascade of events for each receptor, globally 
referred to as ‘receptor trafficking’, is thought to be initiated already at the 
plasma membrane, where receptors are ‘tagged’, e.g. phosphorylated or 
ubiquitinated, to determine their endocytic and postendocytic fates. Receptor 
phosphorylation can occur in response to activation by an agonist and is 
necessary for receptor endocytosis (Premont RT, Gainetdinov RR 2007; 
Ferguson SS et al. 1998). However, it has been suggested that receptor tag not 
only influences endocytosis, but also influences its postendocytic fate, 
regulating interactions with sorting proteins or by inducing other post-
translational modifications (Cao T.T. et al. 1999; Marchese A, Benovic J.L. 
2001). One of the sorting signals for proteins along the exo- and endocytic 
pathways is the ubiquitynation, a post-translational modification by which 
ubiquitin, a polypeptide of 76 amino acid residues, is covalently attached to 
lysine (Lys) residues of a substrate protein (Hershko and Ciechanover, 1992). 
Once thought to only mediate proteasomal degradation in the cytosol (Pickart 
and Fushman, 2004), ubiquitynation might also occur at the plasma 
membrane where it regulates protein internalization, at the trans-Golgi 
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complex where it directs proteins to the late endosomes, and in endosomes to 
sort proteins to the multivesicular bodies (Mukhopadhyay and Riezman 2007; 
Piper and Luzio, 2007). In all these cases, it results in protein degradation into 
the lysosomes. The fate and the transport of the tagged substrate will depend 
on the Lys residue involved in the formation of ubiquitynation chains, as well 
as on the number of residues added. Single ubiquitin monomers can be 
attached to one or several Lys of a protein (mono- or multimonoubiquitylation, 
respectively). Ubiquitin itself possesses several Lys residues that can be used 
for the attachment of another ubiquitin molecule, allowing substrates to be 
modified with different types of ubiquitin chains (polyubiquitynation). 
Ubiquitynation occurs in a stepwise manner involving three enzymes: an 
ubiquitin-activating enzyme E1 is responsible for the attachment of free 
ubiquitin; a second ubiquitin-conjugating enzyme E2 receives it from E1; and a 
third ubiquitin ligase E3 catalyzes the final transfer of the ubiquitin from the 
E2 enzyme to the substrate. The specificity of the ubiquitynation process is 
determined by the E3 ligases, which are suggested to function as an adaptor to 
bind substrates selectively. More than 600 E3 ligases were found in the human 
proteome and were classified into two major groups, defined by the presence of 
either a HECT (homologous to the E6 associated protein C terminus) or a 
RING (really interesting new gene) domain as catalytic domain. Recently, it 
has been emerging that E3 ligases play an important function in regulating T-
cell tolerance and immunity (Bhoj and Chen, 2009; Deshaies and Joazeiro, 
2009; Gomez-Martin et al., 2008). For instance, the E3 ligase c-Cbl regulates 
T-cell receptor (TCR) activation by both degrading key signalling molecules 
such as PLCc-1 (Jeon et al., 2004) and controlling TCR internalization and 
transport to the lysosomes (Naramura et al., 2002). Interestingly, the defective 
expression of some E3 ligases has been related to the development of 
autoimmune diseases, such as encephalomyelitis, arthritis and autoimmune 
diabetes (Chiang et al., 2000; Gronski et al., 2004; Jeon et al., 2004). 
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1.1.3 Human glycoprotein CD8α. 
 
The T-cell coreceptor CD8 is a type I transmembrane protein expressed as αα 
homodimer on the surface of intestinal T cells, γδ T cells, thymic T-cell 
precursors and NK cells, and as αβ heterodimer on thymocytes and peripheral 
T-cells (Gangadharan and Cheroutre 2004, Irie et al. 1995). The surface 
expression of CD8 αβ heterodimer depends on the α chain (Goldrath et al. 
1997), while efficient surface expression of the α chain requires its cytosolic C-
terminal valine motif (C-TVM), a ligand of PDZ domains that modulates its 
delivery to the plasma membrane (PM) by sequentially interacting with 
GRASP65 and GRASP55 proteins (Iodice et al. 2001; D'Angelo et al. 2009). 
Required for the activation of cytotoxic T lymphocytes, CD8 stabilizes the 
interaction between the TCR on the surface of the lymphocytes and the class I 
major histocompatibility complex on antigen-presenting cells. Furthermore, it 
recruits the p56lck protein tyrosine kinase, bound to the cytosolic tail of its α-
chain, to the vicinity of the TCR. CD8 functions as co-activator because Lck is 
a major proximal effector of the T cell activation cascade (Salmond et al. 2009 
Weiss and Littman 1994). Development of cytotoxic T lymphocytes was 
greatly reduced in CD8α-/- mice (Fung-Leung et al. 1991) and defects in 
CD8α and β expression were shown to correlate with pathological conditions 
such as immunodeficiencies and Wiskott-Aldrich syndrome (de la Calle-
Martin et al. 2001, Kawabata et al. 1996, Schmitz et al. 1998). How CD8 
function is regulated at the PM and whether its impairment leads to immune 
diseases is still largely unknown. 
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1.2 Aim of the study. 
 
As it has been mentioned above, the C-TVM of CD8α is important to obtain 
efficient intracellular transport to the plasma membrane (PM) thanks to the 
sequential interaction with GRASP65 and GRASP55 proteins. This binding 
occurs after the incorporation of the receptor into COPII vesicles and it is 
important for the best traffic rate to and through the Golgi complex but not for 
the delivery to the PM. However, is well known the important of PDZ domain 
containing proteins for the stability and dinamics for the receptor at the PM. 
For this reason, the aim of this study was to identify and characterize proteins 
that could modulate CD8α localization at the PM, in C-TVM dependent 
manner. To do this, drs G. D’Angelo and L. Iodice in the lab performed a yeast 
two-hybrid screening using a human liver cDNA library and the CD8α 
cytosolic C-terminal tail as bait (Fig.1A). Among positive clones, one 
contained a cDNA fragment encoding amino acids 56-451 of the LNX2 protein 
(Fig.1B). LNX2 protein was initially identified as ligand of the endocytic 
protein Numb (Ligand of Numb protein X) (Dho et al. 1998; Rice et al. 2001). 
It was classified as RING type E3 ligases, since it contains an N-terminal 
RING finger domain (Fig.1C). However, it has been poorly characterized and 
its function as E3 ligase has never been addressed. In addition, it also contains 
four PDZ domains, presumably mediating protein-protein interaction. The 
cDNA fragment identified by the two-hybrid assay corresponded to the LNX2 
N-terminal region including RING finger domain, the NPAY motif for the 
interaction with Numb and the first two PDZ domains (Fig.1C). Interestingly, 
the interaction was disrupted when the PDZ ligand signal was removed from 
the bait by deletion of the Tyr and Val residues from the C-TVM (CD8-ΔYV) 
(Fig.1B), indicating that the binding between CD8α and LNX2 is strongly 
dependent on this signal. 
My work started to characterize LNX2-CD8α interaction in order to investigate 
the role of LNX2 on the plasma membrane localization of CD8α. 
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1.3 Materials and methods. 
 
 
All of the culture reagents were obtained from Sigma-Aldrich (Milan, Italy). 
The solid chemical and liquid reagents were obtained from E. Merck 
(Darmstadt, Germany), Farmitalia Carlo Erba (Milan, Italy), Serva 
Feinbiochemica (Heidelberg, Germany), Delchimica (Naples, Italy) and BDH 
(Poole, United Kingdom). The radiochemicals were obtained from Perkin 
Elmer (Bruxelles, Belgium). Protein A-Sepharose CL-4B and the ECL reagents 
were from Amersham Biosciences (Milan, Italy). 
 
 
Antibodies 
The following antibodies were used: the OKT8 mouse anti-CD8α monoclonal 
antibody from Ortho (Raritan, NJ, USA); the N1 mouse anti-CD8α monoclonal 
antibody and rabbit anti-CD8α polyclonal antibody from M. Jackson (Martire 
et al., 1996); rabbit anti-LNX1 antibody (Kansaku et al., 2006); rabbit and 
mouse anti-GFP and anti-HA antibodies (Santa Cruz Biotechnology Inc.); 
mouse anti-EEA1 monoclonal antibody (BD Transduction Laboratories, 
Lexington, KY); mouse anti-CD7107a (LAMP1) monoclonal antibody 
(Biolegend); Peroxidase-conjugated anti-mouse and anti-rabbit IgG (Sigma-
Aldrich, Milan, Italy). Texas-Red-conjugated anti-mouse or rabbit IgG, FITC-
conjugated anti-mouse or rabbit IgG and Cy5-conjugated anti-mouse IgG 
(Jackson Immunoresearch Laboratories, West Grove, PA, USA). 
 
 
cDNA cloning and plasmid construction 
The expression vector FLTRβT8 for wild type CD8α and CD8α-ΔYV (Iodice 
et al., 2001; Mottola et al., 2000) and HA-Ubiquitin (Mauro et al., 2006) have 
been previously described. LNX1p80 (ID 4995278) and LNX2 (ID 5541168) 
cDNAs were obtained from I.M.A.G.E. Consortium. GFP-LNX1p80 and GFP-
LNX2 expression vectors were generated by PCR and subcloning of LNX1p80 
and LNX2 cDNAs in the pEGFP-N1 vector (Clontech). 
For in vitro binding assays, GST fused to wild type or ΔYV-mutant CD8α 
were expressed using pGEX-6P-1 (Pharmacia Biotech.). LNX1p80, LNX2 and 
all their truncated forms were subcloned in the expression vector pcDNA3 
(Clontech). The following LNX1p80 cDNA fragments were expressed for the 
in vitro binding assay in Fig.S1: RING-NPAF (1-760bp); RING (1-309bp); 
NPAF (309-760bp); PDZ(1-4) (760-2187bp); PDZ(1-2) (760-1415bp); PDZ(3-
4) (1480-2187bp); PDZ(1) (760-1074bp), PDZ(2) (1114-1415bp). 
The following LNX2 cDNA fragments were expressed for the in vitro binding 
assay in Fig.S1: RING-NPAY (1-666bp); RING (1-340bp); NPAY (510-
666bp); PDZ(1-4) (637-2073bp); PDZ(1-2) (682-1386bp); PDZ(3-4) (1378-
2073bp); PDZ(1) (682-983bp), PDZ(2) (961-1386bp). 
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In vitro binding assay 
LNX1p80 or LNX2 proteins were in vitro translated and labelled by 35S-
methionine using the TnTR coupled reticulocyte lysate system (Promega). 1/2 
of the full-length LNX proteins or fragments producted in vitro were incubated 
with 30 µg of glutathione-Sepharose beads loaded with GST or GST fused to 
wild type or ΔYV-mutant CD8α. Bound proteins were eluted from the beads 
and analysed by SDS-PAGE and autoradiography. In all the GST-pull down 
experiments the loading control (L) represents 20% of the whole amount of in 
vitro translated proteins used for incubation. 
 
 
Cell culture, transfection and immunofluorescence 
Human embryonal kidney HEK293 and human hepatoma Huh-7 cells were 
routinely grown at 37ºC in Dulbecco’s Modified Essential Medium (DMEM), 
containing 10% fetal bovine serum (FBS). HPB-ALL T cells were cultured in 
RPMI 1640, containing 15 % FBS. 
HEK293 and Huh-7 cells were transfected by using FuGene 6.0 according to 
the manifacturer instruction (Roche). The effect of CD8α expression on LNX 
protein localization was obtained by simultaneous cotransfection of CD8α and 
LNX proteins expression vectors and, 40 hrs later, cell fixation or lysis. To 
observe the effect of LNX proteins expression on CD8α localization and 
protein level, cells were initially transfected with LNX proteins expression 
vectors in order to allow LNX proteins accumulation and, 24 hrs later, 
transfected a second time with CD8α expression vectors. Then, after further 24 
hrs, they were either lysed or fixed. 
Indirect immunofluorescence was performed as previously described (Mottola 
et al., 2000). Single confocal images were acquired at 63x and 100x 
magnification on a Meta Zeiss Confocal Microscope (Carl Zeiss, Jena, 
Germany). 
To separately stain CD8α protein on either cell surface (extra) or intracellular 
membranes (intra), after fixation cells were incubated with the rabbit anti-
CD8α polyclonal antibody, then permeabilized and incubated with the mouse 
anti-CD8α monoclonal antibody (Mottola G., et al. 2000). Two distinct 
secondary antibodies allow separately visualizing the two fractions. Then, in 
order to measure the ratio between the plasma membrane and intracellular 
CD8α in cell, immunofluorescence intensity in the two channels was measured 
by using photoshop and ImageJ Biophotonic programs for each cotransfection 
15 cells were considered for quantification. The results are given as mean±SD 
(Standard deviation). 
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Preparation of cell extracts, immunoprecipitation SDS-PAGE and Western 
immunoblotting.  
Cells were lysed with 10mM Tris-HCl pH 7.4/150mM NaCl/ 1mM EDTA pH 
8.0/ 1% Triton X-100. For all the experiments on transfected HEK293, 6 x 106 
cells were lysed and used for each coimmunoprecipitation. For the experiment 
on HPBALL cells, 100 x 106 cells were used for each coimmunoprecipitation. 
Immunoprecipitation was performed by over-night incubation with OKT-8, a 
conformation-sensitive antibody anti-CD8α, followed by adding Protein A-
Sepharose beads (Pharmacia). Immunoprecipitated pellet were washed, treated 
for SDS-PAGE and resolved on a 10% polyacrylamide gels. For each 
experiment aliquots of the lysate (100 µg total protein/each aliquot) were also 
precipitated with acetone and treated for SDSPAGE. Next, proteins were 
transferred to nitrocellulose filters, which were then incubated with primary 
antibodies diluted in blocking buffer (5% non-fat dry milk, 0.1% Tween-20 in 
PBS), followed by peroxidase-conjugated secondary antibodies. For anti-
LNX1p80 and anti-LNX2 antibodies western blot was performed in PBS- 1% 
BSA. After washing, bound antibodies were detected by ECL (Amersham 
Biosciences). CD8α degradation was detected by previously treating cells with 
or without 90µM chloroquine for 16 hours. 
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1.4 RESULTS. 
 
 
1.4.1 CD8α binds the LNX proteins LNX2 and LNX1p80. 
 
To confirm the interaction between LNX2 and CD8α, LNX2 cDNA was in 
vitro transcribed and translated and the radioactively labeled protein was 
incubated with either the CD8α cytosolic C-terminal tail or its ΔYV-mutant 
fused to the GST (see Materials and methods). The bound proteins were 
separated by SDS-PAGE and revealed by autoradiography. As shown in 
Fig.1D, LNX2 associates in vitro with the cytosolic C-terminal tail of CD8α 
(lane 2), but not with its ΔYV-mutant (lane 3). 
LNX2 is closely related to the p80 isoform of LNX1, another member of the 
LNX protein family [Fig.1C, (Dho et al. 1998; Rice et al. 2001)]. However, in 
contrast to LNX2, the function of LNX1p80 as E3 ligase has been partially 
explored (Kansaku et al. 2006; Takahashi et al. 2009). For these reasons, we 
decided to test whether LNX1 is a CD8α binding protein. On the other hand, 
we were not surprised that this protein was not found in our two-hybrid assay, 
since LNX1p80 is poorly expressed in human liver cells (Dho et al. 1998). As 
observed for LNX2, in vitro transcribed and translated LNX1p80 was also able 
to interact with the CD8α cytosolic C-terminal tail fused to the GST (Fig.1D, 
lane 5). The removal of the C-TVM from CD8α decreased such interaction 
(Fig.1D, lane 6). 
CD8α protein is usually present in T and NK cells, but, unfortunately, the low 
level of endogenous CD8α protein did not allow us to co-immunoprecipitate 
LNX proteins from this cell fraction. Therefore, we used the human HPB-ALL 
T-cell line and we demonstrated that in these cells, LNX1p80 and LNX2 were 
pulled down by CD8α (Fig.2A, lanes 2 and 4). Therefore, these data suggested 
that such interactions are also occurring in the physiological context of the T 
cell coreceptor CD8α. In order to further characterize this interaction, we 
decided to shift to a heterologous expression system that could be more easily 
handled and allow higher level of protein expression. Therefore, GFP and 
GFP-tagged versions of LNX1p80 and LNX2 were generated, transfected with 
CD8α in HEK293 cells and then immunoprecipitated from cell lysates by an 
anti-GFP antibody. The presence of CD8α in the precipitates was tested by 
immunoblotting. Fig.2B shows that, consistently with the previous data, 
GFPLNX1p80 (lane 2) and GFP-LNX2 (lane 3), but not GFP (lane 1), were 
able to coimmunoprecipitate CD8α. Likewise, CD8α pulled-down GFP-LNX2 
(Fig.2C, lane 1) and GFP-LNX1p80 (Fig.2C, lane 5). In the absence of CD8α 
C-TVM LNX2 interaction was completely lost (Fig.2C, lane 4), while 
LNX1p80 interaction decreased (Fig.2C, lane 8). Therefore, CD8α in vitro and 
in vivo interacts with LNX2 and LNX1p80 and these interactions require its C-
TVM. 
It has been previously shown that LNX1p80 interacts with the junctional 
proteins JAM-4 via the second PDZ domain (Kansaku et al. 2006) and the first 
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two PDZ domains of LNX2 are required for binding to the cell surface 
coxsackievirus and adenovirus receptor (CAR) (Sollerbrant et al. 2003). To 
identify regions of LNX1p80 and LNX2 important for CD8α recognition, we 
generated a series of truncation mutants, containing separately the distinct 
domains and tested their ability to bind CD8α cytosolic C-terminal tail or its 
ΔYV-mutant fused to the GST (Fig.S2). Consistently with the results of the 
two-hybrid assay, the N-terminal fragment of LNX2 including RING domain, 
NPAY signal and the first two PDZ domains was able, although to a less 
extent, to interact with CD8α tail in YV-dependent manner. However, neither 
the RING domain nor the NPAY motif alone interacted as the full-length 
protein. In contrast, we found that the fragment including all the four PDZ 
domains was indispensable for a proper interaction to CD8α. 
Indeed, its in vitro binding efficiency was comparable to the one observed for 
the fulllength protein (Fig.S2). Moreover, when expressed in HEK293 cells, it 
was coimmunoprecipitated by CD8α (Fig.S3A, lane 3). Among the four PDZ 
domains of LNX2, the first 2 appeared to have a major role, since they were 
sufficient, although to a lesser extent, to bind CD8α tail in YV-dependent 
manner. Similar results were overall observed for the LNX1p80 protein 
(Fig.S2 and S3A), thus fully confirming the observation that LNX1p80 and 
LNX2 interact with CD8α via their four PDZ domains. 
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Fig.1: Identification and characterization of LNX2 and LNX1p80 as 
interacting partner of CD8α. 
(A) The amino acidic sequences of CD8α wild type and ΔYV-mutant cytosolic 
Cterminal tail used as baits in the two-hybrid assay. (B) Identification of the N-
terminal fragment of LNX2 by two-hybrid assay: yeast colony expressing the N-
terminal fragment was able to grow on high-stringency selection plate when co-
transformed with plasmid expressing the CD8α wild type cytosolic tail. No growth 
was detected when either a control plasmid (pGBKT7, vector with the GAL4 DNA 
binding domain) or a plasmid expressing the ΔYV-mutated tail was cotransformed. 
CNTR represents yeast colony transfected with the vector expressing only the GAL4 
activation domain, which grew at low extent in all the transformations. (C) Schematic 
representation of LNX2 and LNX1p80. LNX proteins contain a RING finger domain, 
an NPAY/NPAF motif for interaction with Numb protein and 4 PDZ domains. The 
line underneath LNX2 indicates the fragment obtained by two-hybrid assay. (D) In 
vitro interaction between either LNX2 or LNX1p80 and the cytosolic tail of CD8α. 
Glutathione-sepharose beads, loaded with GST fused to CD8α wild type (lanes 2 and 
5) or ΔYV mutant cytosolic tail (lanes 3 and 6), were incubated with 35S-
methioninelabelled in vitro-translated LNX2 (lanes 2 and 3) or LNX1p80 (lanes 5 and 
6). Bound proteins were eluted from the beads and analyzed together with the loaded 
samples (L, lanes 1 and 4) by SDS-PAGE and autoradiography. Numbers indicate 
molecular mass (kDa). 
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Fig.2: In vivo interaction between CD8α and either LNX2 or LNX1p80. 
(A) CD8α was immunoprecipitated from human HPB-ALL T cells lysates and 
visualized by immunoblotting. A control was also performed by using mouse IgGs. 
Arrowheads point CD8α, which was immunoprecipitated with the mouse OKT-8 
antibody (lane 2 and 4), but not with mouse IgGs (lane 6). The presence of either 
LNX1p80 (lane 4) or LNX2 (lane 2) in the immunoprecipitates was revealed with 
specific antibodies. In the control immunoblotting was performed by comcomitantly 
using anti-LNX1p80 and anti-LNX2 antibodies (lane 6). Aliquots (100 µg) of total 
proteins were precipitated and loaded (L). However, CD8α and LNX proteins (lanes 
1,3 and 5) were poorly detectable in these fractions. Asterisks mark the 
immunoglobulin light chains revealed by immunoblotting. (B) CD8α was expressed 
with GFP (lane 1), GFP-LNX1p80 (lane 2) or GFP-LNX2 (lane 3) in HEK293 cells. 
After 24-hrs transfection, LNX proteins were immunoprecipitated from cell lysates by 
an anti-GFP antibody and visualized by immunoblotting. The presence of CD8α in the 
immunoprecipitates was revealed with with anti-CD8α antibody. Lysates were also 
analysed by imunoblotting with anti-tubulin antibody as loading control. (C) CD8α or 
CD8α-ΔYV was expressed alone (lanes 2,3,6,7) or together with either GFP-LNX2 
(lanes 1,4) or GFP-LNX1p80 (lanes 5,8) in HEK293 cells. After 24-hrs transfection, 
CD8α was immunoprecipitated from cell lysates and visualized by immunoblotting. 
The presence of LNX proteins in the precipitates was revealed with an anti-LNX2 
(lanes1-4) or anti-GFP (lanes 5-8) antibody. Numbers indicate molecular mass (kDa). 
CHAPTER	  I	  
Results	  
1.4	  	  
	   17	  
1.4.2 CD8α expression leads to redistribution of LNX1p80 or 
LNX2 to the plasma membrane. 
 
In order to identify the intracellular localization of LNX1p80 and LNX2 in 
mammalian cells, GFP- or HA-tagged constructs of the two proteins were 
generated and expressed in HEK293 cells. GFP-LNX1p80 exhibited both a 
cytosolic and nuclear localization (Fig.3a), as previously described (Zheng et 
al. 2010). In contrast, GFP-LNX2 was exclusively cytosolic (Fig.3i). 
Remarkably, we found that this localization was changed upon simultaneous 
expression of wild type CD8α, since both GFP-LNX1p80 (Fig.3, c-e) and 
GFP-LNX2 (Fig.3, k-m) appeared to redistribute at the plasma membrane, 
where CD8α localized as well. In addition, GFP-LNX2 was also recruited by 
CD8α at the Golgi complex (Fig.3, k-m, arrowheads). Interestingly, HA-tagged 
fragments containing the four PDZ domains of either LNX1p80 or LNX2 were 
also relocated at the plasma membrane upon CD8α coexpression (Fig.S3B, a-c, 
g-i). Moreover, as expected, expression of the CD8-ΔYV did not have any 
affect on the intracellular distribution of all these chimeric proteins (Fig.3, f-h, 
n-p, and Fig.S3B, d-f, j-l). These results confirmed that CD8α interacts in live 
cells with LNX1p80 and LNX2, strongly suggesting a functional role of these 
interactions. 
 
 
 
 
Fig.3: CD8α expression leads to redistribution of LNX1p80 or LNX2 to 
the plasma membrane. 
GFP-LNX1p80 (green, a-h) or GFP-LNX2 (green, i-p) was expressed in HEK293 
cells alone (a-b, i-j) or together with either CD8α (c-e, k-m) or CD8-ΔYV (f-h, n-p). 
After 24- hrs transfection, cells were fixed and immunostained for CD8α (red). (e, h, 
m, p) merge. Yellow arrowheads in k-m indicate colocalization between CD8α and 
GFP-LNX2, presumably at the Golgi complex. A single confocal section is shown. 
Scale bar, 3 µm. 
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1.4.3 LNX1p80 and LNX2 promote ubiquitination of CD8α. 
 
Next, we examined whether LNX1p80 was able to ubiquitinate CD8α, as 
previously described for claudin (Takahashi et al. 2009), and whether also 
LNX2 was equipped of ubiquitination activity. For this purpose, we 
coexpressed CD8α, HA-tagged ubiquitin and either GFP, GFP-LNX1p80 or 
GFP-LNX2 in HEK293 cells (Fig.4). After 24-hrs transfection, CD8α was 
immunoprecipitated from cell lysates and its level of ubiquitination was 
analyzed by immunoblotting with an anti-HA antibody (Fig.4). In contrast to 
the control (lane 1), a pattern of HA signal was found in the presence of the 
coexpressed GFP-LNX1p80 (lane 2) or GFP-LNX2 (lane 3). Since the 
cytosolic tail of CD8α has three potential Lys residues for ubiquitination 
(Fig.1A), the lower bands visualized by the anti-HA antibody (asterisks) might 
correspond to monoubiquitination of a single, double or triple Lys residues, 
respectively. Higher bands, possibly corresponding to polyubiquitinated forms, 
and a smear pattern were detected exclusively when CD8α was coexpressed 
with LNX2 (lane 3). These results clearly indicated that both LNX1p80 and 
LNX2 induce CD8α ubiquitination. 
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Fig.4: LNX1p80 and LNX2-dependent ubiquitination of CD8α. 
Plasmids expressing CD8α, HA-tagged ubiquitin and GFP, GFP-LNX1p80 or 
GFPLNX2 were transiently co-transfected in HEK293 cells. After 24 hrs, CD8α was 
immunoprecipitated and the ubiquitinated CD8α fraction (Ub-CD8) was revealed by 
an anti-HA antibody. Total lysates were also analyzed by immunoblotting with anti-
CD8α antibody. GFP-tagged LNXs were immunoprecipitated with a GFP mAb and 
revealed with an anti-GFP pAb. The asterisks indicate ubiquitinated CD8α bands, 
which might correspond to monoubiquitination of single, double or triple Lys 
residues, respectively. The parenthesis indicates the smear pattern and higher 
molecular weight ubiquitinated CD8α forms detected only in the presence of LNX2. 
Numbers indicate molecular mass (kDa). 
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1.4.4 LNX1p80 and LNX2 control CD8α localization at the 
plasma membrane. 
 
While we were performing the immunofluorescence experiments on HEK293 
cells, we observed a strong reduction of CD8α level at the PM in cells that 
expressed high levels of LNX proteins expression (data not shown). In order to 
verify and clearly visualize this effect, we decided to shift to the human 
hepatoma cell line Huh-7, because these cells are bigger and more spread than 
the HEK293, allowing a better visualization of protein localization at the PM. 
Moreover, we changed our transfection procedure by initially transfecting cells 
with GFP-LNX1p80, GFP-LNX2 or GFP and, only after 24 hrs, with CD8α. 
This allowed us to accumulate high level of LNX proteins in cells already 
before CD8α expression. Then, after further 24 hrs, cells were fixed and, 
before detergent permeabilization, directly treated with an anti-CD8 polyclonal 
antibody to uniquely label CD8α fraction localized at the PM. Cells were then 
permeabilized and the CD8α intracellular fraction was revealed by using an 
anti-CD8 monoclonal antibody. As shown in Fig.5, upon coexpression with 
either GFP-LNX1p80 (e-h) or GFP-LNX2 (i-l), the amount of CD8α localized 
at the PM was strongly decreased in comparison to cells expressing CD8α 
alone (f, j) or together with GFP (a-d). We quantified this decrease by 
measuring the ratio between the PM (extra) and intracellular (intra) signal 
detected by immunofluorescence (for quantification see Materials and 
methods). As shown in Fig.5, in respect to the control CD8/GFP coexpression, 
only ~50% of CD8α at the PM was detected upon GFP-LNX1p80 or GFP-
LNX2 coexpression. Therefore, we concluded that LNX1p80 and LNX2 
modulate CD8α protein level at the plasma membrane. 
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Fig.5: High expression level of GFP-LNX1p80 and GFP-LNX2, but not 
GFP, induces CD8α downregulation from the plasma membrane. 
Huh-7 cells expressing by the new transfection procedure CD8α and high level of 
GFP (a-d), GFP-LNX1p80 (e-h) or GFP-LNX2 (i-l) were fixed and analyzed by 
indirect immunofluorescence. (b, f, j) cells stained for CD8α before permeabilization 
in order to label the CD8α fraction localized on the PM (CD8 ext, red); (c, g, k) cells 
stained for CD8α after permeabilization to label the CD8α intracellular fraction (CD8 
int, blue). (d, h, l) merge. GFP (a, green), GFP-LNX1p80 (e, green) or GFP-LNX2 (i, 
green) expression is shown. On the bottom, the ratio between the external and the 
internal CD8α fraction quantified for the three distinct cotransfections as described in 
Materials and methods. A single confocal section is shown. Scale bar, 3 µm. 
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1.4.5 LNX1p80 and LNX2 are involved in endocytic trafficking 
and degradation of CD8α. 
 
The monoubiquitination of CD8α and its downregulation from the PM in the 
presence of LNX1p80 and LNX2 strongly suggested that the two LNX proteins 
are involved in CD8α internalization and degradation. To address this 
hypothesis, Huh-7 cells expressing by the new transfection procedure high 
level of GFP-LNX1p80, GFP-LNX2 or GFP together with CD8α were 
examined by immunofluorescence using antibodies specific for an early 
endosomes marker EEA1 and a lysosomal marker, LAMP1, in order to detect 
the accumulation of CD8α into endocytic compartments. We found that in the 
presence of either GFP-LNX1p80 (Fig.6 and 7, e-h) or GFP-LNX2 (Fig.6 and 
7, i-l), concomitantly to its downregulation from the PM, a fraction of CD8α 
accumulated in EEA1 or LAMP1-positive compartments (Fig.6 and 7, e-l, 
arrowheads). In contrast, when transfected alone (Fig.6, f, j) or with GFP 
(Fig.6 and 7, a-d), CD8α was not significantly detected in endocytic structures 
and mostly visualized at the PM. Similar results were also observed in 
HEK293 cells (data not shown). 
Next, we examined whether CD8α downregulation from the PM observed by 
the new transfection procedure resulted in the coreceptor degradation. We have 
previously observed that simultaneous cotransfection of CD8α and GFP-LNX 
proteins induced CD8α ubiquitination but did not decrease the total amount of 
CD8α in the whole lysate (Fig.4, lanes 1-3). In contrast, Fig.8 clearly shows 
that, on equal conditions of cotransfection efficiency and input protein level 
(tubulin protein level), when GFPLNX1p80 (lane 2) or GFP-LNX2 (lane 3) are 
highly expressed, the total amount of CD8α in the whole lysate was smaller 
than that of GFP-coexpressing cells (lane 1). 
Remarkably, such effect on CD8α was not observed, when CD8α was 
coexpressed with the HA-tagged PDZ domains of either LNX1p80 or LNX2 
(lanes 4 and 5), which bind CD8α (Fig.S2 and Fig.S3), but lack the RING 
domains. To understand whether this degradation takes place into the 
lysosomes, we treated cells with the lysosome inhibitor chloroquine (Fig.8, 
lanes 6-10) and found that the amount of CD8α in the whole lysate was 
significantly increased by this treatment (lanes 7 and 8). These data strongly 
suggest that LNX1p80 and LNX2 induce CD8α transport to the lysosomes and 
degradation. 
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Fig.6: High expression level of GFP-LNX1p80 and GFP-LNX2, but not 
GFP, promotes CD8α transport to the early endosomes. 
Huh-7 cells expressing by the new transfection procedure CD8α and high level of 
GFP (a-d), GFP-LNX1p80 (e-h) or GFP-LNX2 (i-l) were fixed and stained for CD8α 
(b, f, j, red) and the early endosomes marker EEA1 (c, g, k, blue). (d, h, l) merge. 
Higher magnification of the cell areas marked in panels by the yellow lines is shown 
at the bottom. Arrowheads indicate endocytic structures where CD8α colocalizes with 
GFPLNX1p80 or GFP-LNX2, but not GFP. A single confocal section is shown. Scale 
bar, 3 µm. 
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Fig.7: High expression level of GFP-LNX1p80 and GFP-LNX2, but not 
GFP, promotes CD8α transport to the lysosomes. 
Huh-7 cells expressing by the new transfection procedure CD8α and high level of 
GFP (a-d), GFP-LNX1p80 (e-h) or GFP-LNX2 (i-l) were fixed and stained for CD8α 
(b, f, j, red) and the lysosomal marker LAMP1 (c, g, k, blue). (d, h, l) merge. Higher 
magnification of the cell areas marked in panels by the yellow lines is shown at the 
bottom. Arrowheads indicate endocytic structures where CD8α colocalizes with 
GFPLNX1p80 or GFP-LNX2, but not GFP. A single confocal section is shown. Scale 
bar, 3µm. 
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Fig.8: Lysosomal degradation of CD8α protein in cells highly expressing 
either GFP-LNX1p80 or GFP-LNX2. 
HEK293 cells expressing, by the new transfection procedure, CD8α and high level of 
GFP (lanes 1 and 6), GFP-LNX1p80 (lanes 2 and 7), GFP-LNX2 (lanes 3 and 8), 
Hatagged PDZ1-4 domains of LNX1p80 (lanes 4 and 9) or LNX2 (lanes 5 and 10), 
were cultured with or without chloroquine treatment. After cell lysis, CD8α protein 
was immunoprecipitated from equal cell lysate aliquots and revealed by 
immunoblotting. In parallel, equal cell lysate aliquots were used to reveal GFP and 
GFP-tagged LNX proteins with an anti-GFP mAb, and HA-tagged PDZ domains of 
LNX1p80 and LNX2 with an anti-HA mAb. Lysates were also analyzed by 
immunoblotting with anti-tubulin antibody as loading control. Numbers indicate 
molecular mass (kDa). 
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Fig.S1: The four PDZ domains of either LNX1p80 or LNX2 mediate in 
vitro the interaction with CD8α . 
List of the LNX2 and LNX1p80 constructs generated and in vitro tested for their 
ability to interact with GST-fused either to the wild type or to the ΔYV-mutant 
cytosolic tail of CD8α. Bound proteins were eluted from the beads and analyzed 
together with the loaded samples (L) by SDS-PAGE and autoradiography.  
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Fig.S2: CD8α  interacts in vivo with the four PDZ domains of either 
LNX1p80 or LNX2. 
(A) In vivo interaction between CD8α and the four PDZ domains of either LNX1p80 
or LNX2. CD8α  (lanes 1,3) or CD8-ΔYV (lanes 2,4) was expressed together with 
HA-tagged PDZ domains of either LNX1p80 (lane 1,2) or LNX2 (lane 3,4) in 
HEK293 cells. After 24-hrs transfection, CD8α was immunoprecipitated from cell 
lysates and visualized by immunoblotting. The presence of LNX1p80 or LNX2 
fragments in the precipitates was revealed with an anti-HA antibody. Numbers 
indicate molecular mass (kDa). 
(B) CD8α expression redistributes the four PDZ domains of either LNX1p80 or 
LNX2 to the plasma membrane. HA-tagged PDZ domains of either LNX1p80 (a-f) or 
GFP-LNX2 (g-l) were expressed in HEK293 cells together with either CD8α (a-c, g-i) 
or CD8-ΔYV  (d-f, j-l). After 24-hrs transfection, cells were fixed and immunostained 
for CD8α (red) and HA (green). (c, f, i, l) merge. Yellow arrowheads indicate 
colocalization at the plasma membrane. A single confocal section is shown. Scale bar, 
3 mm. 
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1.5 CONCLUSION. 
 
In this work, we identify and characterize the interaction between the human 
coreceptor CD8α and LNX1p80 and LNX2 proteins. These results show that 
this binding occurs in vitro and in vivo and mutually affects the localization of 
each partner: CD8α recruits LNX1p80 or LNX2 from the cytosol to the plasma 
membrane, while, remarkably, LNX1p80 or LNX2 expression leads to CD8α 
ubiquitination, downregulation from the PM, endocytosis and degradation. 
RING-based E3 ligases confer specificity to ubiquitination by recognizing 
target substrates. Accordingly, they have been linked to the control of many 
cellular processes and to multiple human diseases. However, despite their 
relevance, the functional characterization of most of them remains at a 
rudimentary stage (Deshaies and Joazeiro 2009). The activity of LNX1 as E3 
ubiquitin ligase has been recently explored. Two splicing variants of LNX1 
exist, the p70 and p80. The LNX1p70 binds the junctional protein JAM4 and 
its overexpression facilitates JAM4 endocytosis (Kansaku et al. 2006). On the 
other hand, LNX1p80 is an interacting partner of claudin-1 and promotes its 
ubiquitination, removal from the tight junctions and transport to the lysosomes 
(Takahashi et al. 2009). Interestingly, LNX1 downregulation has been 
associated to gliomas (Chen et al. 2005) and to the cardiovascular Kawasaki 
infectious disease (Burgner et al. 2009), indicating its indispensable relevance 
for the proper functionality of distinct tissues and organs. In contrast to LNX1, 
LNX2 has been poorly studied and the only interacting protein so far identified 
was the cell surface coxsackie- and adenovirus receptor (CAR) (Mirza et al. 
2006). No information was available to date whether LNX2 behaves, similarly 
to LNX1, as an E3 ubiquitin ligase in mammalian cells. Here, we shed much 
light on the function of both LNX proteins: we demonstrate that they are 
expressed in human T lymphocytes and we identify an important novel partner 
for them, the human TCR coreceptor CD8α. This finding suggests that LNX 
proteins play a role in the regulation of T-cell tolerance and immunity, as the 
E3 ligase c-Cbl, which also has a RING finger domain (Jeon et al. 2004, 
Naramura et al. 2002). Future work will be addressed to test this interesting 
hypothesis. While the anterograde transport of CD8α and β chains along the 
exocytic pathway has been described (D'Angelo et al. 2009, Erra et al. 1999, 
Goldrath et al. 1997, Pascale et al. 1992), whether and how CD8 localization 
at PM is regulated by endocytic trafficking and which signals and cellular 
machineries are involved is so far largely unknown. The identification of the 
LNX ubiquitin ligases as interacting protein of CD8α, their redistribution at the 
PM upon CD8α expression and the effect of LNX protein expression on CD8α 
localization and expression contribute to answer these questions and it will 
help to understand how impairment of CD8 function and localization at the PM 
might lead to immune diseases. It will be interesting to investigate whether and 
how LNX proteins regulate the localization of CD8 αβ heterodimer as well. 
Despite the strong similarity between LNX1p80 and LNX2 structure and 
function, potentially interesting differences may distinguish them. In contrast 
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to LNX1p80, LNX2 is recruited by CD8α also to the Golgi complex; its 
interaction is more severely dependent on the C-TVM of CD8α, and LNX2 
expression induces also a smear pattern of ubiquitination, which might 
correspond to CD8α polyubiquitinated forms. Intriguingly, while mono- or 
multimono-ubiquitination has been notably involved in endocytosis 
(Mukhopadhyay and Riezman 2007), polyubiquitination has been also 
associated to direct sorting from the Golgi to the vacuole of the yeast protein 
Gap1 (Soetens et al. 2001). Therefore, LNX2 might be also involved in the 
regulation of CD8α transport to, through or from the Golgi complex, which has 
been already shown to be strongly dependent on the C-TVM of the co-receptor 
(D'Angelo et al. 2009). Further work is required to verify such hypothesis. 
In conclusion, our results identify two major interacting partners of the human 
coreceptor CD8α, providing the first link between the possible regulation of the 
function of CD8α at the plasma membrane of lymphocytes and ubiquitination, 
endocytosis and lysosomal degradation. 
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CHAPTER II 
 
 
Alpha B-Crystallin over-expression reverts the dominant 
negative effect of mutant Frizzled4 L501fsX533 (disease gene 
for a dominant form of familial exudative vitreoretinopathy). 
 
 
2.1.1 Abstract. 
 
Familial exudative vitreorethinopaty (FEVR) is an hereditary ocular disorder 
caused by an insufficient vascularization of the periferal retina during 
development. The resulting hypoxia actives a compensatory vascularization but 
the new vessels are prone to rapture causing exudates and bleeding followed by 
scarring, retinal detachment and blindness. Mutations in Frizzled4 (Fz4), a 
member of the cell surface Wnt family receptors, were found in many FEVR 
patients. In a autosomal dominant form of FEVR (the most frequent and 
henceforth referred as Fz4-FEVR), the deletion of two nucleotides leads to the 
synthesis of a completely different and truncated cytosolic tail (L501fsX533). 
This receptor is retained in the ER and somehow traps Fz4 by oligomerization, 
thus performing its dominant effect. 
We confirmed the ER retention of Fz4-FEVR in transfected cells and observed 
the formation of oligomers of high molecular weigth in a time dependent 
manner, suggesting that oligomerization plays a role in the localization of the 
mutant. Interestingly, when we replaced the cytosolic tail of the G glycoprotein 
coded by the ts-045 mutant strain of VSV (VSVG) with the tail of wilde-type 
or mutant receptor, the chimeric VSVG-Fz4-FEVR was completely retained in 
the ER, whereas VSVG-Fz4 exited from the ER. Thus, the Fz4-FEVR tail is 
sufficient to determine ER localization. In addition, performing a competition 
experiment, we found that overexpression of a peptide coding FEVR tail 
resulted in the recovery of the cell surface expression of Fz-FEVR, suggesting 
that its retention in the ER is protein-mediated. 
Most importantly, we found with a proteomic approach a new interactor of 
both Fz4wt and Fz4-FEVR, the αB-Crystallin protein. This interaction was not 
tail dependent, suggesting that the three cytosolic loops of the receptor may be 
involved. αB-Crystallin overexpression promoted cell surface expression of 
Fz4-FEVR and prevented its dominant negative effect on the wild-type 
counterpart. Thus, αB-Crystallin might represent an important tool to contrast 
FEVR. Current effort is focused to identify the specific interactor(s) 
responsible of the retention in the ER of Fz4-FEVR in order to identify others 
possible therapeutic target(s). 
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2.1.2 Exit from the ER. 
 
Although the secretory pathway in eukaryotic cells has been intensively 
studied, fundamental issues, such as the molecular mechanisms of ER exit, still 
remain elusive. Two different models have been proposed: cargo capture and 
bulk flow. In the cargo capture model, proteins are recognized by cargo 
receptors and concentrated in ER exit sites and COPII vesicles. According to 
the bulk flow model, secretory proteins move out of the ER as part of the bulk 
fluid or membrane of departing vesicles in a receptor independent manner, 
although both are COPII dependent (Belinda A. et al. 2001). The fundamental 
difference between the two models is that in the cargo capture, cargo proteins 
are selectively recognized and their transport is actively promoted (Wieland 
F.T. et al. 1987). In contrast, resident proteins are tought to remain into the ER 
because mostly excluded from COPII vesicles by weak (lateral) interaction 
with variety of proteins in the lumen of the ER forming a sort of “matrix”. 
Most of the resident proteins into the ER are chaperones involved in the 
assisting of the folding newly synthesized proteins. 
Numerous signal motifs can tightly regulate the export process from the ER. 
To date, several classes of ER export motifs have been identified in the 
cytosolic tails of transmembrane proteins. These  export signals, characterized 
in non-GPCR transmembrane proteins, can be divided into several classes. 
Among them, diacidic motifs DxE or ExD, have been identified in the 
cytosolic C-termini of the vesicular stomatitis viral glycoprotein (VSVG), 
cystic fibrosis transmembrane conductance regulator (CFTR), Kir2.1 
potassium channel, Angiotensin II Receptors (Nishimura N. et al. 1997, Ma D. 
et al. 2001, Xiaoping Zhang et al. 2011) and many other proteins (Melanie 
Mikosch and Ulrike Homann. 2009). The DxE motif directs the concentration 
of the cargo molecule during ER export, thereby enhancing the rate of its exit 
from the ER. Mutation of the DxE motif to AxA does not affect VSVG 
molecule assembly but slow down the ER exits of about 10-fold (Nishimura 
N. et al. 1999). Adding DxE motif confers transport ability to sufficiently 
direct the export of other proteins, which are normally retained in the ER. 
Specifically, this motif is required for the interaction of VSVG with Sec23/24 
in a ternary pre-budding complex consisting of Sar1-GTP, cargo, and Sec23/24 
(Nishimura N., Balch W.E. 1997). More recently, it has been identified a new 
diacidic export motif ExxD that facilitates ER export of SYP31 and may 
function for type I and type II proteins in plants (Laurent Chatre et al. 2009). 
Similarly, the double phenylalanine motif (FF), is required for efficient 
transport of the p24 family proteins and ERGIC-53 from the ER to the Golgi 
(O. Nufer et al. 2002, O. Nufer et al. 2003). Notably, the substitution of FF 
motif with a di-hydrophobic signal as VV, LL, VL, IL, IV, or V alone, 
produces the same ER export capacity for ERGIC-53 (O. Nufer et al. 2003). 
NKCC2 requires the tri-hydrophobic motif LLV in the distal COOH terminus 
for the ER exit and cell surface expression (Nancy Zaarour et al. 2009). 
Furthermore, a single C-terminus alanine in the cytosolic tail of Major 
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histocompatibility complex class I (MHC-I) molecole is crucial for its correct 
cell surface expression, as well as a single C-terminal valine of the cytosolic 
tail of Frizzled 4 and 7 where its removal strongly slow down the exiting form 
the ER (Sunglim Cho et al. 2011, Heike Hering, Morgan Sheng. 2002, 
Giovanni D’Angelo et al. 2009). Thus, all these evidences demonstrate that the 
export from the ER is selectively regulated by specific aminoacids, although 
the deletion or substitution of these residues doesn’t abrogate the capacity to 
exit from the ER, according to the bulk flow model described above (Belinda 
A et al. 2001). Increasing evidences suggest that the phosphorylation signal 
plays a critical role in protein targeting to the plasma membrane. For example, 
extracellular signalling that activates phosphoinositide 3-kinase (PI3K) causes 
a significant increase in the surface expression of voltage-gated calcium 
channels and transient receptor potential channels (Viard P. et al. 2004, 
Bezzerides V.J. et al. 2004). In the KCNK3 potassium channel, the deletion of 
a 14-3-3 binding motif (SWTY) results in a substantial loss of surface 
expression, implicating the influence of the phosphorylation signal on the 
cargo protein (O’Kelly I. et al. 2002, Rajan S. et al. 2002). Indeed, 14-3-3 
binding to the SWTY motif is dependent on phosphorylation and thus relies on 
the activity of kinases that phosphorylate this motif. In particular, Akt, a 
downstream kinase of PI3K, directly phosphorylates the SWTY sequence 
under fetal bovine serum or growth factor stimulation, and recruits 14-3-3, 
which subsequently confers the cell surface expression of the SWTY-carrying 
reporter potassium channel (Jean-Ju Chung et al. 2009). Similarly, 14-3-3 
promotes cell surface expression of GPR15, a G protein-coupled receptor 
(GPCR) that serves as a co-receptor for HIV. Also in this case, the binding 
of14-3-3 to this receptor requires a phosphorylation of the S359 residue in 
cytosolic tail (Yukari Okamoto and Sojin Shikano 2010). 
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2.1.3 Export trafficking of G protein-coupled receptors.	  
 
G protein-coupled receptors (GPCRs) are a superfamily of cell-surface 
receptors that regulate a variety of cell functions by responding to a myriad of 
ligands. The superfamily includes the Frizzled receptors which have a similar 
structure to GPCRs although clearly distinct functional properties (see Frizzled 
receptors section). GPCR expression level at the cell surface is a balance of 
three highly regulated, dynamic intracellular trafficking processes, namely 
export, internalization and degradation. 
Recent efforts to elucidate the mechanism underlying GPCR export from the 
ER have led to the identification of several motifs in the membrane-proximal 
carboxyl termini which play a critical role in their export from the ER 
(Schulein R. et al. 1998). 
 
The export motifs can be grouped in different classes: 
• E(x)3LL motif: The role of the LL motif has been controversial, although it 
has been demonstrated that the LL motif together with an upstream 
glutamate (E) residue [E(x)3LL] in the carboxyl terminus of the vasopressin 
V2 receptor is essential for its cell surface expression (Matthew T. et al. 
2005). 
• F(x)3F(x)3F motif: A triple phenylalanine motif [F(x)3F(x)3F] has been 
identified in the membrane-proximal carboxyl terminus of the dopamine D1 
receptor that is required for its cell-surface expression (Jason C. Bermak et 
al. 2001). 
• FN(x)2LL(x)3L motif: Recently, it has been demonstrated that a dileucine 
and surrounding hydrophobic residues, namely upstream phenylalanine (F) 
and asparagine (N) and downstream leucine (L), constitute an ER-export 
motif [FN(x)2LL(x)3L] within the membrane-proximal carboxyl terminus of 
the human vasopressin V1b/V3 receptor. Mutations of one or more of these 
five hydrophobic residues reduce receptor expression at the plasma 
membrane, indicating that the integrity of FN(x)2LL(x)3L motif is required 
for receptor export from the ER (J. Robert et al. 2005). 
• F(x)6LL motif: Utilizing a strategy of progressive truncation and alanine-
scanning mutagenesis, it has been demonstrated that F436 and I443L444 in the 
carboxyl terminus of α2B-AR and F309 and L316L317 in the carboxyl terminus 
of AT1R are required for receptor export from the ER (M.T. Duvernay et 
al. 2004). 
 
These motifs are required for GPCR export from the ER. However, the 
molecular mechanism underlying their function remains unclear. There are 
several possibilities regarding their role in GPCR ER export. First, similarly to 
DxE and FF motifs, these motifs may function as independent ER-export 
signals, autonomously mediating receptor export from the ER. Consistent with 
this possibility, the F(x)3F(x)3F, FN(x)2LL(x)3L and F(x)6LL motifs confer 
transport capabilities to the ER-retained proteins. However, unlike the DxE and 
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FF motifs, there is no evidence that any of these motifs directly associate with 
the components of the COPII vesicles. Second, the motifs may be involved in 
proper receptor folding in the ER. In order to pass through the ER quality 
control, GPCRs have to be correctly folded. Incompletely folded or misfolded 
receptors cannot pass the ER quality control mechanism are targeted for 
degradation. Accordingly, the F(x)3F(x)3F motif mediates the interaction of the 
dopamine D1 receptor with the ER chaperone protein DRiP78 (Jason C. et al. 
2001). Although the intrinsic structural determinants for the export trafficking 
of G protein-coupled receptors (GPCRs) have been mainly identified in the N- 
and C-terminus of the receptors, recently it has been identified a single Leu 
residue, present in the first intracellular loop, that is essential for the export of 
α2B-AR, β2-AR, AT1R and α1B-AR from the ER (REFF). 
	  
CHAPTER II	  
ER localization mediated by recycling	  
2.1.4	  	  
	   35	  
2.1.4 ER localization mediated by recycling. 
 
The ER lumen contains a variety of soluble proteins that perform essential 
functions related to protein folding and assembly. Munro and Pelham were the 
first to show that ER resident proteins are distinguished by the presence of a C-
terminal KDEL sequence (HDEL in yeast) that prevents their secretion 
(Munro, S. and Pelham, H.R. 1987). The finding that KDEL-proteins can be 
modified by post-ER enzymes indicated that these proteins are retrieved from 
Golgi cisternae (Pelham H.R. 1988, Dean N. and Pelham H.R. 1990). Thus, 
the ER retention is a dinamic process mostly based on the continous recyling 
from downstream compartment of proteins “erroneously” escaped form the 
ER. Following the discovery of the KDEL signal, and the first KEDL receptor 
(KDELR) (Lewis M.J. et al. 1992; Heli I. et al. 2011) many variants of the 
signal have been described. Recently, 35 variants of KDEL signal, along with 
the specificity code of the three human KDEL receptors have been identify 
(Heli I. et al. 2011). These authors proposed a PROSITE motif for ER 
localization that is currently [KRHQSA]-[DENQ]-E-L. In humans, a 
distinction between the various signals is achieved by differential specificities 
of the three KDELRs. Although some overlap exists, it appears that each 
KDEL receptor mediates the retrieval of a subgroup of soluble ER proteins 
(Lewis M.J. et al. 1992). The KDELR was shown to be present in purified 
COPI vesicles, and to colocalize with coatomer in buds and vesicles of 
permeabilized cells, GTPγS treated. In contrast to cargo proteins, uptake of the 
KDELR into COPI vesicles does not depend on the hydrolysis of GTP, 
underlining its role as machinery rather than cargo (Wilson D.W. et al. 1993). 
Sorting of membrane proteins into COPI vesicles often depends on cytosolic 
signals that mediate their binding to coat components. The best characterized is 
the carboxy-terminal di-lysine motif K(X)KXX, found in some ER-resident 
proteins and in cycling proteins that function at the ER-Golgi interface 
(ERGIC53/ p58, and in p25) (Teasdale R.D., Jackson M.R. 1996). Several 
studies suggest that the efficiency of the KKXX signal depends on both the X 
residues and on the distance of the signal from the membrane (Vincent M.J. et 
al. 1998). The potency of the K(X)KXX motif, in conjunction with the 
efficiency of ER exit, determines whether at steady state a protein is mainly 
ER-localized, or whether it distributes between the ER, ERGIC and Golgi 
compartments. The dilysine motif interacts with coatomer, and this interaction 
is required for the retrieval of tagged proteins to the ER (Stornaiuolo M et al. 
2003). In particular, in the Wbp1 protein, dilysine motif was found to interact 
with a subcomplex of coatomer consisting of the α-, β'- and ε-COP subunits 
(Letourneur F. et al. 1994). Subsequently, two-hybrid assays and functional 
analysis showed that the binding is mediated by the N-terminal WD40 
propeller domains of the α- and β'-COP subunits (Eugster A. et al. 2004). 
Arginine (Arg)-based motifs represent an additional important class of ER 
localization signals conforming to the consensus [ΥΩR]–R–X–R (where Υ/Ω 
is an aromatic or bulky hydrophobic residue) (Michelsen K. et al. 2005). First 
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identified in the invariant chain of the major histocompatibility complex class 
II (MHC-II), this signal is often found on subunits of multimeric complexes 
such as cell-surface receptors and ion channels (Lotteau V. et al. 1990, Schutze 
M.P. et al. 1994). It couples complex assembly to cell-surface transport by 
maintaining unassembled subunits in the ER; upon correct assembly, the signal 
is inactivated, allowing for ER export. Several mechanisms have been 
proposed for signal inactivation: steric masking by intersubunit interaction 
following proper assembly, hindrance of the signal by multivalent binding of 
14-3-3 proteins, binding of PDZ-domain proteins, protein phosphorylation 
(Yuan H. et al. 2003, Mrowiec T. and Schwappach B. 2006, Oliver Nufer and 
Hans-Peter Hauri. 2003). Unlike KXKXX signals, the positioning of Arg-
based signals is not confined to the extreme C-terminus, and the signal may 
appear in multiple copies along the cytosolic domains of membrane proteins. 
The ability of Arg signals to interact with coatomer suggests that ER 
localization is due to COPI-mediated retrieval transport (Rohan D. Teasdale 
and Michael R. Jackson. 1996). Recent studies in yeast identified two highly 
conserved stretches in the β- and δ-COP subunits of coatomer that are required 
collectively for the binding of Arg-based motifs (Michelsen K. Et al. 2005). 
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2.1.5 Oligomerization: export or retention in the ER? 
 
Protein–protein interactions are crucial to the organizational structure and 
function of cell signalling networks. Many classes of receptors and other signal 
transducer polypeptides form constitutive or regulated dimers and/or higher 
order oligomers (P.J. Woolf, J.J. Linderman 2004). 
Several studies have demonstrated the capacity of G protein-coupled receptors 
(GPCRs) to form homo-dimers/oligomers. These interactions are important for 
cell surface delivery. Moreover, the organizational structure of the complexes 
may also be central for the molecular mechanisms leading to G protein binding 
and activation. Recently, the potential for hetero-dimeric/oligomeric 
interactions between different GPCRs has also been explored by co-expression. 
The results indicate that the interactions can influence ligand pharmacology, 
the type of the generated signals and cellular trafficking of the complexes. 
Several evidences suggest that GPCR dimerization occurs at the level of 
protein synthesis in the endoplasmic reticulum or during protein maturation in 
the Golgi apparatus (Graeme Milligan et al. 2007). Dimerization/ 
oligomerization of both gonadotropin receptors FSH and LH is a pre-requisite 
for cell surface expression of the complex and it occurs constitutively in the 
early biosynthetic pathway (Tao Y.X. et al. 2004, Thomas R.M. et al. 2007, 
Guan R. et al. 2009, Guan R. et al. 2010). However, misfolded human LHR 
mutants are retained in the ER and, in addition to homodimerization,  they may 
also form heterodimers with the Wt receptor thus acting as a dominant negative 
(Guan R. et al. 2009). Thus, in this case oligomerization favor the absence of 
the ER export. Accordingly, the introduction of a ER retention motif into 
GPCRs not only results in lack of cell surface delivery of the modified receptor 
but can also inhibits cell surface delivery of a co-expressed unmodified 
receptor. For example, the replacement of the C-terminal tail of β2-
adrenoceptor with the equivalent region of the GABAb-R1 subunit, which 
contains a well-characterized arginine-based ER retention signal, results in ER 
trapping of the modified β2-adrenoceptor. This modification also limits cell 
surface delivery of co-expressed wild type β2-adrenoceptor. In addition to the 
introduction of ER retention motifs into GPCRs, mutations in a variety of 
positions can eliminate or limit cell surface trafficking of a receptor and the 
mutants may act as dominant negatives for cell surface delivery of wild type 
receptors (Salahpour A. et al. 2004). 
Interestingly, at variance with above results, gap junction Connexin 43 (Cx43), 
which is able to form multimeric channels, exit from the ER as a monomer and 
subsequently oligomerizes in the Golgi complex. This seems to be due to a 29-
kDa thioredoxin-family protein (ERp29) that, acting as a chaperone, helps to 
stabilize the monomeric form of Cx43 in the ER. When Cx43 reaches the 
Golgi complex, ERp29 leaves Cx43 and is recycled to the ER thanks to KDEL-
based retrieval motif (Shamie Das et al. 2009). 
All together, these data indicate that the oligomerization status of the receptors 
is crucial for their delivery to the plasma membrane and in particular for the 
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export from the ER. Interestingly, in some cases, oligomeric status is crucial 
for masking specific ER retention motifs or to form a stable complex that is 
capable to escape the quality control in order to exit from the ER. In contrast, 
oligomeric complex can be the cause of the dominant negative effect of 
mutated receptor retained in the ER.  
Importantly, several ER-retained GPCR mutants can be rescued by treatment 
with chemical or pharmacological chaperones, an approch that has potential 
therapeutic implications in all diseases associated with ER-retained receptor 
mutants (J.H. Robben et al. 2006, Tao Y.X. 2006). In addition, beyond to the 
chemical and pharmacological chaperones, cell surface expression of some 
receptor, like Cardiac Potassium Channel hERG, can be rescued by growing 
the cells that express these receptors to a lower temperature (Eckhard Ficker 
et al. 2003, Jayasri Nanduri et al. 2009). 
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2.1.6 Frizzled receptors. 
 
Frizzleds (Fzs), are cell surface receptors involved in a variety biological 
processes during development as well as in adult life. Human as well as mouse 
genome has 10 different genes that codify for 10 different receptors. The 
primary structure of all ten mammalian Fzs display many landmarks observed 
in virtually all G protein-coupled receptors, including an ectosolic N-terminus 
that is N-glycosylated, seven hydrophobic transmembrane segments predicted 
to form α-helixes, and three intracellular and extracellular loops, and a 
cytosolic tail that harbor potential sites of protein phosphorylation (Fig10). 
Putative glycosylation sites on the extracellular loops of Fzs could be involved 
in ligand binding and have been shown to be important for receptor maturation 
in ER, which is regulated in a specific manner by the protein Shisa (Yamamoto 
A. et al. 2005). Sequence and mutational analyses revealed the presence of two 
PDZ (PSD-95/dics large/ZO-1 homologous) binding domain in the cytosolic 
tail, providing a protein-interacting interface for the receptor. The 
juxtamembrane KTxxxW motif is conserved among all 10 Fz receptors, while 
the second PDZ-binding motif, at the C-terminus of the receptors, is present 
only in Fz-1, -2, -4, -7 (Annouck Luyten et al. 2008) (Fig.10). The 
extracellular domain of Fzs can bind several secreted molecules and some are 
considered to be cognate ligands. The primary endogenous agonists are the 
WNT proteins, of which there are 19 mammalian forms. These proteins are 
able to trigger most of the Fz-mediated signaling pathways.  
However, recent findings suggest that at least three other protein families can 
directly bind Fzs and activate downstream signaling: soluble Frizzled-related 
proteins (soluble FRPs), R-spondin and Norrin. R-spondin and Norrin were 
shown to interact with the CRD (cystein reach domain), while sFRPs were 
initially seen as WNT scavengers that prevented WNT binding to Fzs. 
However, recent studies support the idea of direct binding of sFRPs to Fz-
CRDs, probably by CRD dimerization followed by receptor activation, as in 
the case of sFRP1-mediated activation of Fz2 (Rodriguez, J. et al. 2005). 
 
                                        
CHAPTER II 
Frizzled receptors 
2.1.6 
 
	   40	  
 
 
Fig.10: Schematic view of the assembly in the membrane of Fz receptors:  
The model indicates extra and intracellular interacting proteins, putative glycosylation 
and phosphorylation sites. The N-terminal CRD is the primary binding site for 
ligands. The red stretch in the C terminus indicates the internal PDZ-interacting motif 
(KTxxxW), which is absolutely conserved in the different Fz isoforms and necessary 
for DVL binding and signaling. The blue stretch at the C-terminus indicates the 
presence of a classical, less well-conserved PDZ-ligand sequence present in a subset 
of Fz. 
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The main signaling pathways (Fig.11) activated by all 10 Frizzled receptors 
are: 
1. Fz/β-catenin pathway: agonist stimulation results in the activation of the 
phosphoprotein Dishevelled (DVL), leading to inhibition of a 
constitutively active glycogen-synthase kinase 3 within a destructive 
complex consisting of APC (adenomatous polyposis coli) and axin, 
which regulates the phosphorylation and destruction of b-catenin. The b-
catenin thus spared is translocated to the nucleus, where it cooperates 
with TCF/LEF transcription factors tomodify gene transcription (Gordon 
M.D. and Nusse R. 2006). 
2. Fz/Ca2+ pathway: The agonists induce elevation of intracellular calcium 
levels in a G-protein-dependent manner either directly, through 
activation of phospholipases (Slusarski D.C. 1997), or indirectly, via a 
decrease in intracellular cyclic GMP (Ma L. and Wang H.Y. 2006), 
resulting in activation of calcium-dependent kinases, such as 
calciumdependent protein kinase (PKC) and Ca2+/calmodulin-dependent 
protein kinase. 
3. Fz/PCP (planar cell polarity) pathway: The information is believed to 
be transduced via DVL to the small GTPases RHO and RAC and their 
effectors, which are mainly ROCK (RHO kinase) and the c-jun-
Nterminal kinase-c-jun-AP1 pathway (Seifert J.R. and Mlodzik M. 
2007). 
 
Mutagenesis has revealed that several residues in the intracellular loops and in 
the C-terminal domain of Fzs are crucial for signaling. Specifically, the 
mutation of the highly conserved internal KTxxxW motif in the C terminus, or 
single amino acid exchanges in the first (R340A) or the third (L524A) 
intracellular loops of human Fz5, completely abolished Fz signaling. 
Importantly, identical mutations completely ablated the binding of DVL (DSH 
in Xenopus and Drosophila) and its membrane recruitment by Fzs (Cong F. et 
al. 2004).  
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Fig.11: Schematic representation of the Wnt signaling pathways:  
(a) The canonical, Wnt/b-catenin pathway. Binding of the Wnt ligand to the Fz and to 
the co-receptor of the LRP family leads to phosphorylation of Dishevelled (Dsh/Dvl), 
and to titration of Axin away from the β-catenin degradation complex, composed of 
APC, GSK-3 and Axin itself. As a consequence, the degradation complex cannot 
assemble, β-catenin is stabilized and translocates to the nucleus where, together with 
transcription factors of the Tcf/Lef family, it activates Wnt target genes, such as c-myc 
and cyclin D1. (b) The non-canonical, β-catenin independent pathways: the PCP and 
the Ca2+ pathway. A main branch of the PCP downstream of Dsh/Dvl involves the 
small GTPases of the Rho family, Rac and c-Jun N-terminal kinase (JNK). Dsh/Dvl 
can also stimulate calcium flux and protein kinase C (PKC) and calmodulin-dependent 
protein kinase II (CAMKII). The non-canonical Wnt signaling controls cell movement 
and tissue polarity. Heparan sulfate proteoglycans (HSPG) are known to bind and to 
concentrate Wnt at the cell surface and to influence Wnt signaling. 
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2.1.7 Familial exudative vitreoretinophaty (FEVR). 
 
Familial exudative vitreoretinopathy (FEVR) is characterized by failure of 
peripheral retinal vascularization. The visual problems and variable phenotype 
associated with FEVR result from secondary complications caused by retinal 
ischemia. The retinal avascularity is probably present from birth and generates 
sequelae that stabilize in early adult life or progress in later life. Expressivity 
may be asymmetric and is highly variable, ranging from mild or asymptomatic 
to severe (e.g., registered as blind) within the same family. The diagnosis of 
FEVR is based on bilateral peripheral retinal avascularity diagnosed by indirect 
ophthalmoscopy and fundus fluorescein angiography. Four genes are known to 
be associated with FEVR: FZD4, encoding for Fz4 receptor, LRP5, encoding 
for low-density lipoprotein receptor-related protein 5 (Johane Robitaille, et al. 
2002), NDP, encoding for the secreted protein Norrin, that is one of the 
principal agonist Fz4 ligands (Katherine B Sims, MD. 2009) and TSPAN12, a 
member of the tetraspanin superfamily (James A. Poulter et al. 2010). In all 
cases, mutations affect the activation of the pathway promoted by Fz4 receptor. 
As it as been shown that Fz4 signaling regulates endothelial cells (EC)/mural 
cells (MC) interactions and is essential for vascular integrity in the retina and 
cerebellum (Xin Ye et al. 2009). Furthermore, Fz4 is present throughout the 
developing and adult vasculature, and its inactivation results in severe vascular 
disorganization. It has been shown, cultured Fz4-/- retinal embrional cells 
(RECs) are unable to form capillary-like structures but can integrate into these 
structures when they are formed by WT RECs. Moreover, Norrin/Fz4/Lrp 
signaling controls a transcriptional program in endothelial cells that is, at least 
partially, mediated by Sox17. These results establish Norrin/Fz4/Lrp signaling 
as a central regulator of REC development, and they indicate that the 
hypovascularization responsible for FEVR, Norrie disease or osteoporosis-
pseudoglioma syndrome arises from the impairment of a specific 
transcriptional program. They also suggest that Fz4/Lrp signaling could play a 
role in vascular growth, remodeling, and maintenance in a variety of normal 
and pathologic contexts beyond the retina (Xin Ye et al. 2009). 
Among all described mutations associated to the FEVR, only the Fz4 
L501fsX533 is associated to the dominant form, that is also the relatively most 
frequent (Kondo H. et al. 2003). This mutation consists in a deletion of a di-
nucleotide (ct) in 1501-1502 position in exon2 of the FZD4 gene that results in 
a frameshift mutation that starts at the leucine in position 501 and finishes in 
position 533 where it introduces an early stop codon. In transfected cells, the 
effect of this mutation is the total absence of the mutant receptor on the plasma 
membrane (Johane Robitaille et al. 2002). Most importantly, in the same 
condition, the mutant receptor acts as a dominant negative by trapping the 
wild-type counterpart in the ER by oligomerization (Kaykas A. et al. 2004). 
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2.2 Aim of  the study. 
 
It was previously shown that the C-terminal PDZ binding motif of the receptor 
Fz4 is crucial for its efficient cell surface expression (D’Angelo et al. 2009). 
However, the removal of the two last C-terminal valine residues, part of the C-
terminal PDZ binding motif, resulted only in the rediction of cell surface 
expression of the wild-type receptor (about 60%). This result was due to the 
loss of the interaction with the GRASP proteins which is crucial for the correct 
and sequential transport of the receptor to and throught the Golgi complex. 
Such interaction is lost also by the mutant Fz4-FEVR that, surprisingly, is 
completely absent from the plasma membrane and mostly retained in the ER. 
Thus, the loss of the interaction with GRASPs only partially explain the ER 
retention of Fz4-FEVR, suggesting the existence of a further mechanism to 
prevent cell surface expression of the mutant receptor. The aim of the present 
work was to identify this molecular mechanism and to define approaches for 
obtaining cell surface expression of functional Fz4 receptors in Fz4/Fz4-FEVR 
expressing cells, i.e. a first step to envisage therapeutic perspectives for the 
cure of adFEVR. 
	  
CHAPTER II 
Materials and Methods 
2.3 
 
	   45	  
2.3 Materials and methods. 
 
 
All culture reagents were obtained from Sigma-Aldrich (Milan, Italy). Solid 
chemicals and liquid reagents were obtained from E. Merck (Darmstadt, 
Germany), Farmitalia Carlo Erba (Milan, Italy), Serva Feinbiochemica 
(Heidelberg, Germany), Delchimica (Naples, Italy) and BDH (Poole, United 
Kingdom). The radiochemicals were obtained from Perkin Elmer (Bruxelles, 
Belgium). Protein A-Sepharose CL-4B and the ECL reagents were from 
Amersham Biosciences (Milan, Italy). Protease Inhibitor Cocktail was obtained 
from Roche (Milan, Italy). 
 
Antibodies 
The following antibodies were used: mouse monoclonals anti-GFP and anti-
HA (Santa Cruz Biotechnology Inc.); rabbit polyclonal anti-HA (Sigma 
Aldrich); mouse monoclonal anti-FLAG (Sigma Aldrich); mouse monoclonal 
anti-γTubilin (Santa Cruz Biotechnology Inc.); rabbit polyclonals anti-Calnexin 
(StressGene), anti-GM130 (Marra et al., 2001), rabbit anti-Sec31 (Marra et al., 
2001); mouse monoclonals anti-ERGIC53 (Marra et al., 2001) anti-CRYAB 
(Enzo Life Sciences) anti-CD7107a (LAMP1) (Biolegend); Peroxidase-
conjugated goat anti-mouse and anti-rabbit IgG (Sigma-Aldrich, Milan, Italy). 
Texas-Red-conjugated goat anti-mouse or rabbit IgG, FITC-conjugated goat 
anti-mouse or rabbit IgG and Cy5-conjugated goat anti-mouse IgG (Jackson 
Immunoresearch Laboratories, West Grove, PA, USA). 
 
 
cDNA cloning and plasmid construction 
The construct pCDNA5-HA-Fz4 was kindly provided by M. MacDonald and 
M.R. Hayden. The mutant L501fsX533 (Fz4-FEVR) was obtained by site 
direct mutagenesis using the following oligos: 
 
Fz4-FEVR 
Fw: 5’-TGGTCTGCCAAAACTTCACACGTGGCAGAAG-3’ 
Rv: 5’-AGTTTTGGCAGACCAAATCCACATG-3’ 
 
 
The expression vector pCMV6-XL5 for human alpha Crystallin B-chain 
(hCRYAB) (ID NM_001885.1) protein was obtained from I.M.A.G.E. 
Consortium. 
 
To obtain the construct 3xFLAG-hCRYAB, the cDNA coding for the human 
alpha crystallin B-chain was amplified by PCR using the following oligos 
containing HindIII/XbaI flanking restriction sites: 
 
Fw (HindIII): 5’-AAGCTTATGGACATCGCCATCCACCACCC-3’ 
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’ 
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To obtain the construct 3xFLAG-hCRYAB (R120G) in which the R120 was 
substituted with a glycine (G), the construct 3xFLAG-hCRYAB was used as a 
template and the site direct  mutagenesis assay was performed according to the 
manufacturer instruction (Roche) using the following oligos: 
 
Fw: 5’-CTCCAGGGAGTTCCACGGGAAATACCGGATCCCAG-3’ 
Rv: 5’-GTGGAACTCCCTGGAGATGAAACC-3’ 
 
 
To obtain the constructs 3xFLAG-Fz4-wt or FEVR tails, the region encoding 
for the tails of the Fz4-wt or Fz4-FEVR were isolated from the cDNAs of the 
proteins and subcloned in the 3xFLAG-CMV-7.1 expression vector by using 
the following oligos containing BglII/XbaI flanking restriction sites: 
 
Fz4-wt tail 
Fw (BglII): 5’-AGATCTATGGACATCGCCATCCACCACCC-3’ 
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’ 
 
Fz4-FEVR tail 
Fw (BglII): 5’-AGATCTATGGACATCGCCATCCACCACCC-3’ 
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’ 
 
 
To obtain the constructs 3xFLAG-VSVGts045-Fz4wt tail and 3xFLAG-
VSVGts045-Fz4-FEVR tail, the regions encoding for the ectodomain and 
transmembrane domain (LTM) of VSVG and the tailes of Fz4wt or Fz4-FEVR 
were isolated from the cDNAs of the respective proteins and subcloned in the 
3xFLAG-CMV-7.1 expression vector by using the following oligos: 
 
VSVG (LTM) 
Fw (HindIII): 5’-AAGCTTAAGTTCACCATAGTTTTTCC-3’ 
Rv (BglII): 5’-AGATCTGAGAACCAAGAATAGTCC-3’ 
 
Fz4-wt tail 
Fw (BglII): 5’-AGATCTATGGACATCGCCATCCACCACCC-3’ 
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’ 
 
Fz4-FEVR tail 
Fw (BglII): 5’-AGATCTATGGACATCGCCATCCACCACCC-3’ 
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’ 
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Cell culture, transfection and immunofluorescence. 
Human HEK293T, Huh-7 and COS-7 cells were routinely grown at 37ºC in 
Dulbecco’s Modified Essential Medium (DMEM), containing 10% fetal bovine 
serum (FBS) and transfected by using FuGene 6.0 according to the 
manifacturer instruction (Roche). 
To obtained the dominant negative effect of Fz4-FEVR on the wild-type 
counterpart, COS-7 cells were transiently transfected as previously described 
(Kaykas A. et al. 2004). Indirect immunofluorescence was performed as 
previously described (Mottola G., et al., 2000). Single confocal images were 
acquired at 63x and 100x magnification on a LSM510 Zeiss Confocal 
Microscope (Carl Zeiss, Jena, Germany). 
To separately stain Fz4 proteins on either cell surface (extra) or intracellular 
membranes (intra), indirect immunofluorescence was performed as previously 
described (Mottola et al., 2000; D’Agostino M., et al. 2011). In order to 
measure the ratio between plasma membrane and intracellular staining, the 
immunofluorescence intensity in the two channels was measured by using 
photoshop and ImageJ Biophotonic programs. For each transfection, 10 cells 
were considered for quantification. The results are given as mean±SD 
(Standard Deviation). 
 
 
 
Preparation of cell extracts, immunoprecipitation SDS-PAGE and Western 
immunoblotting.  
Cells were lysed in B-Buffer (10mM Tris-HCl pH 7.4, 150mM NaCl pH 8.0, 
1% Triton X-100) for 30 minutes on ice. 6 x 106 HEK293T cells were lysed 
and used for each co-immunoprecipitation. Immunoprecipitation was 
performed by over-night incubation with mouse monoclonal or rabbit 
polyclonal anti-HA antibody followed by Protein A-Sepharose beads 
(Pharmacia). The immunoprecipitated pellet were washed, treated at 37°C for 
15 minutes for SDS-PAGE and resolved on a 10% polyacrylamide gels. For 
each experiment aliquots of the lysate (100 µg total protein/each aliquot) were 
precipitated with acetone and treated for SDS-PAGE. Proteins were 
subsequently transferred to nitrocellulose filters (D’Agostino M., et al. 2011), 
which were incubated with primary antibodies diluted in blocking buffer (5% 
non-fat dry milk in PBS1X), followed by peroxidase-conjugated secondary 
antibodies. After washing, bound antibodies were detected by ECL (Amersham 
Biosciences). 
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Pulse-Chase & EndoH assay. 
HEK293T cells, transiently transfected with HA-Fz4 and HA-Fz4-FEVR for 
48hrs, were starved with a modified DMEM without CYS/MET aminoacids, 
containing 1% FBS. After 30 minutes the cells were incubated (PULSE) for 20 
or 30 minutes with the same modified DMEM containing 35S-CYS/MET 
(100µci/ml). After washing with PBS1X the cells were incubated (CHASE) for 
2 and 4hrs with the unmodified DMEM 10% FBS containing cycloheximide 
(inhibitor of protein biosynthesis). After washing with PBS1X, HA-Fz4 and 
HA-Fz4-FEVR proteins were immonoprecipitated by using a mouse 
monoclonal anti-HA antibody for 16hrs at 4°C followed by Protein A-
Sepharose beads (Pharmacia). After washing with the buffer used for the lysis, 
the immunoprecipitated proteins were treated with EndoH enzyme, according 
to the manufacturer's instructions, and analyzed by SDS-PAGE. 
 
 
 
Velocity gradient. 
Cell lisates, diluted in glycerol at the final concentration of 6%, were loaded on 
the top of discontinuous 20 to the 40% glycerol gradients (5ml final volume). 
After ultracentrifugation in the SW40.1 rotor at 45000 rpm of 16hrs, 13 
fractions were collected from the bottom of the gradient. All fraction were 
precipitated in 15% TCA for 2hrs at 4°C. After 30 minutes of centrifugation, 
the pellets were washed two times with ice cold acetone, solubilized in 
Laemmli Buffer and analyzed by SDS-PAGE. 
 
 
 
Temperature shift assay. 
Huh-7 cells were cultured on coverslips and transfected with different VSVG 
constructs. After 2hrs at 37°C, cells were incubated at the non permessive 
temperature of 40°C for 16hrs. After this period, the first coverslips were fixed 
in formaldehyde 3,7% while the others were cultured at 10°C or 15°C for 2hrs 
before the fixation. Huh-7 cells, transiently transfected with Fz4 and its mutant 
Fz4-FEVR, were culture for 48hrs at 37°C and then incubated at 10°C or 15°C 
for 2hrs before fixation. 
 
 
 
Competition assay in-vivo. 
Huh-7 cells were transiently transfected with HA-Fz4 or HA-Fz4-FEVR alone 
or togheter 3xFLAG-Fz4wt tail or 3xFLAG-Fz4-FEVR tail and after 48hrs at 
37°C were fixed and processed for immunofluorescence analysis. 
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2.4 RESULTS. 
 
 
2.4.1 Intracellular localization of Fz4-FEVR. 
 
In order to precisely determine the intracellular site(s) of accumulation of Fz4-
FEVR along the secretory pathway, HuH7 cells (Mottola G. et al. 2002; 
Stornaiuolo M. et al. 2003) were transiently transfected (Fig.S3 A1, A2) and 
analyzed by confocal immunofluorescence microscopy.  The extent of 
colocalization with proteins marker of the ER, ERES, IC, Golgi and endosomal 
compartment was measured. As illustrated in Fig.12A, Fz4 resulted scarcely 
present in the ER and ERES, more in the IC and mostly in the Golgi complex, 
as expected for a cell surface protein (comprising a trace amount in the 
endosomal compartment). In contrast, Fz4-FEVR appeared almost entirely 
confined in the ER and not significantly present in any other compartment of 
the secretory pathway. The results obtained by confocal immunofluorescence 
were strongly supported by pulse-chase labeling experiments followed by Endo 
H resistance assays performed in HEK293T cells (Fig.12B). Fz4 reached a 
50% resistance after a 4 hours chase, indicating its transit through the trans-
Golgi en-route toward the plasma membrane; while Fz4-FEVR did not acquire 
any resistance to Endo H digestion within the 4 hours chase. Therefore, we 
concluded that a peculiar and very strong molecular mechanism must 
determine the tight localization in the ER of Fz4-FEVR. 
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Fig.12: Fz4 is retained in the endoplasmatic reticulum. 
A) Fz4-FEVR is almost entirely located in the ER of transfected Huh7 cells. Confocal 
immunofluorescence analysis of the localization of Fz4, Fz4-FEVR N-terminally tagged 
with HA epitope in comparison to markers of the intracellular compartments: Calnexin 
(ER), Sec-31 (ERES), ERGIC-53 (ERGIC), GM130 (cis-Golgi), Lamp-1 (late 
endosomes). Inset magnification of the box area. The percent of colocalization is shown 
in the upper-right punnel. 
B) Fz4-FEVR is not exported to the Golgi complex in transfected HEK293T cells. 
Lysates from cells pulse-chase labeled with S35-CYS and -MET as indicated were 
treated with Endoglycosidase H and analyzed on SDS-gels after immunoprecipitation. 
The position on the gel of the Endo H resistant (R) and sensitive (S) and native (N) of 
forms of Fz4 constructs is indicated on the right. 
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2.4.2 Fz4-FEVR forms with time oligomers of high molecular 
weight in the ER. 
 
Based on the evidence that Fz4-FEVR traps its wild-type counterpart in the ER 
by oligomerization, and that chimaeric wild-type receptor, forced to form 
aggregates, is totaly retained in the ER (Kaykas A. et al. 2004), we speculated 
that an abnormal oligomerization could explain the lack of export from the ER 
of the mutant receptor. 
In order to investigate the oligomerization grade of Fz4 and Fz4-FEVR, 
HEK293T cells were transiently transfected (Fig.S3 A1, A2). After 48hrs the 
cells were collected, detergent lysed and aliquots of the lysates were loaded on 
the top of glycerol gradients prepared and analyzed as described in the material 
and methods section. In the Fig.13A are shown the sedimentation profiles of 
BSA and thyreoglobulin (hTG), used as standard molecular weight. Given that 
the molecular weight of the BSA is very similar to that of the monomeric form 
of Fz4 receptor, we considered the receptor present in the fractions 1-6 as 
monomeric, while that present in fractions 7-13 oligomeric (either homo- and 
heteroligomeric). Thus, Fz4 was mostly present as a monomer while Fz4-
FEVR formed oligomers of high molecular weight. In contrast, as shown in the 
Fig.13B, when the newly syntesized forms of Fz4 and Fz4-FEVR were 
analyzed after 30 min pulse with 35S-Met and -Cys, a clearly different result 
was obtained: the sedimentation profiles of Fz4 and Fz4-FEVR were very 
similar, showing the presence of about 50% of both monomeric and oligomeric 
forms. This result is conceivable with the notion that the folding of complex 
transmembrane proteins may require time and the interaction with a number of 
chaperone proteins present in the lumen of the ER. Therefore, a likely 
conclusion is that the form of Fz4 component for ER export is the monomeric 
one, which is acquired with time by the newly synthesized chain. Indeed, the 
results of Endo-H analysis after pulse-chase labeling are fully in support of this 
hypothesis, showing a slow transport of Fz4 to the medial/trans Golgi (50% in 
4 hours). According to this view, the absence of Fz4-FEVR export from the ER 
would not be caused by its oligomerization: in contrast, the oligomerization 
shown by the mutant at steady-state would be the conseguence of the severely 
impaired transport. 
CHAPTER II 
Results 
2.4 
 
	   52	  
       
 
Fig.13: Oligomerization state of Fz4 and Fz4-FEVR. 
A) Fz4-FEVR accumulates mostly as oligomeric complexes in transfected HEK293T 
cells. Aliquots of cell lysates were analyzed on 20-40% glycerol gradients followed by 
SDS-gels. BSA and human thyreoglobulin (hTG) were used as MW markers for the 
gradient. B) Newly synthesized Fz4 and Fz4-FEVR show the same extent of 
oligomerization. Transfected cells were pulse-labeled for 30 minutes and the lysates 
analyzed as in (A). Fz4 constructs of each fractions were immunoprecipitated, 
resolved on SDS-gel, and revealed by autoradiografy. 
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2.4.3 The cytosolic C-terminal tail of Fz4-FEVR is sufficient for 
the ER localization of a reporter protein. 
 
If the lack of ER export of Fz4-FEVR would not primarily depend on its 
abnormal oligomerization, the first candidate would clearly be the new 
cytosolic tail acquired with the frame-shift mutation. To address this question, 
we generated chimaeric proteins between the VSVG glycoprotein coded by the 
ts-045 mutant strain (Fig.S3.B1) (Balsh et al. 2006) and the cytosolic tail of 
Fz4 and Fz4-FEVR as indicated in Fig.S3.B3 and B4. Given that Fz4-FEVR 
misses the C-TVM, a motif that highly improves cell surface expression of Fz4 
receptor (D’Angelo et al. 2009), to better analyze the effect of the Fz4-FEVR 
tail on the VSVG reporter we used the mutant VSVG form in which its 
cytosolic diacidic motif is substituted with alanine residues (VSVG-AXA) 
(Fig.S3.B2) (D’Angelo et al. 2009). As shown in Fig.14B and D, this mutant 
was less present on the surface of transfected Huh-7 cells in comparison to 
VSVG.  
Most interestingly, when the cytosolic tail of VSVG-AXA was substituted with 
the Fz4 counterpart, a similar accumulation of the chimaera at the cell surface 
was detected (VSVG-Fz4 tail, Fig.14C and D); but almost no expression of the 
Fz4-FEVR tail containing chimaera was measured at the cell surface (VSVG-
Fz4-FEVR tail, Fig.14C and D).  
Finally, to demonstrate that the Fz4-FEVR tail was impairing the ER to Golgi 
transport of the chimaeric proteins, we first accumulated the transfected 
proteins in the ER by incubating the cells at 40°C and then shifted the 
temperature to 32°C for 20 min. As shown in Fig.14E, the VSVG-Fz4-FEVR 
protein did not exit from the ER as well as the VSVG tail-less mutant 
(Fig.S3.B5), while the VSVG-Fz4 protein behaved very similarly to the 
VSVG-GFP. In conclusion, these results indicated strongly that the cytosolic 
C-terminal tail of Fz4-FEVR is sufficient to determine ER localization of a 
very different transmembrane protein (VSVG, type-I single transmembrane 
domain; Fz4-FEVR, multi-spanning 7 transmembrane domains). 
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Fig.14: The Fz4-FEVR tail is sufficient for ER retention of a reporter 
protein. 
A) Huh-7 cells, transiently transfected with ts0-45 VSVG-GFP or VSVG-AXA-GFP 
were grown at the permissive temperature of 32°C and fixed and analyzed by indirect 
immunofluorescence after 48hrs. The extracellular staining was evaluated using a anti-
VSVG  rabbit polyclonal antibody before permeabilization (surface), while total 
staining was evaluated by the GFP signal (total). B) Huh-7 cells, transiently 
transfected as in (A) with indicated chimeric constructs. Extracellular staining was 
obtained using a anti-FLAG mouse monoclonal before permeabilization (surface); the 
total expression was evaluated using the same antibody after permeabilization (total). 
C) Grafic rappresentation of the percent of cell surface expression of the experiments 
shown in (A,B).  
D) Parallel cultures Huh-7 cells were transfected with indicated constructs and 
incubated for 16hrs at 40°C. The cells were fixed before or after 20 minutes of 
incubation at 32°C. 3xFLAG-VSVG-tail less was used as a negative control. 
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2.4.4 The ER localization mechanism of Fz4-FEVR is saturable. 
 
Given that the cytosolic tail of Fz4-FEVR was sufficient to determine ER 
localization, two main hypothesis could be advanced to explain the tight 
localization of the mutant receptor in the ER. First, it may drive a massive self 
interaction of Fz4-FEVR chains excluding their entry into the COPII. Second,  
it may mediate the interaction with other protein(s) that would determine ER 
localization. In principle, the main difference of the 2 envisaged mechanisms is 
that only the second is saturable. To address this hypothesis, the cytosolic tail 
of Fz4 and Fz4-FEVR were engineered in 3xFLAG expression vectors 
(Fig.S3.C1 and C2) and expressed by co-transfection as cytosolic peptides 
together with full-lenght Fz4 or Fz4-FEVR assembled in the ER membrane. As 
shown in Fig.15, almost no effect on cell surface expression level was 
observed when Fz4 was transfected alone or with either one of the two 
3xFLAG plasmids; in contrast, in the presence of its competing tail, Fz4-FEVR 
was clearly expressed on the cell surface, scoring about 1/3 of the value of Fz4 
alone. Most importantly, this effect was specific, as shown by the total absence 
of Fz4-FEVR surface expression in the presence of the Fz4 tail (Fig.15). Thus, 
the most likely explanation for this results is that Fz4-FEVR has acquired the 
capacity to interact with novel partner protein(s) that are responsible for its ER 
localization. 
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Fig.15: The ER localization mechanism of Fz4-FEVR is saturable. 
Huh-7 cells were transiently transfected with indicated constructs for 48hrs and 
processed for triple indirect immunofluorescence microscopy. On the right, the 
histrogram shows the percent of cell surface expression of full length Fz4 receptors 
obtained as specified in material and methods. 
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2.4.5 Possible mechanism for ER retention of Fz4-FEVR. 
 
As shown in Fig.12A, Fz4-FEVR  colocalized almost only with calnexin, 
marker of the ER, while Fz4 was detected at the ERES, intermediate 
compartment and Golgi complex, as expected for a protein en route toward the 
plasma membrane. These results suggest that a retention, rather than a 
recycling mechanism, would trap Fz4-FEVR in the ER. However, based on the 
slow rate of export to the Golgi complex of (Fig.12B) it is also possible that the 
tight ER localization of Fz4-FEVR could be the result of a reduced export rate 
followed by an efficient recycling mechanism to the ER. To check this 
hypothesis, Huh-7 cells were transiently transfected with the chimeric proteins 
VSVG-Fz4, VSVG-FEVR, VSVG-GFP or VSVG-AXA-GFP and incubated at 
10°C or 15°C for 2 hrs, after 16hrs at the non permessive temperature of 
39,5°C required for the ER accumulation. It is well documented that at 10°C 
the export from the ER is blocked at the ERES and visualized by 
immunofluorescence with an increased co-localization with COPII proteins 
(D’Angelo G. et al. 2009). Similarly, at 15°C, the transport to the Golgi 
complex is arrested in the ERGIC, clearly recognizable for its accumulation of 
ERGIC-53 proteins (D’Angelo G. et al. 2009). Thus, if Fz4-FEVR would at 
least in part exit from the ER and recyle from the ERGIC and the cis-Golgi, it 
should be trapped (and visualized) at low temperature in the respective 
localization. As shown in Fig.16, after 2hrs at 10°C, the chimeric VSVG-Fz4 
tail showed a significant score of co-localization with Sec-31 as well as 
VSVG-AXA-GFP. More important, the chimeric VSVG-Fz4-FEVR tail 
showed a significant percent of co-localization with Sec-31, thus showing its 
entry in the ERES. Intriguingly, after 2hrs at 15°C, while both VSVG-AXA-
GFP and VSVG-Fz4wt tail were significantly detected in ERGIC-53 positive 
structures, about no signals of VSVG-Fz4-FEVR was detectable (Fig.17). 
Prompted by these results, Huh-7 cells were transiently transfected with HA-
Fz4 and HA-Fz4-FEVR, incubated at 37°C for 48hrs and then shifted at 10°C 
or 15°C for 2hrs in order to validate the result obtained with the chimaeric 
constructs. As shown in Fig.18A, Fz4-FEVR was significantly detected in Sec-
31 positive structures after 2hrs at 10°C, but much less in ERGIC-53 positive 
compartment at 15°C (Fig.18B). 
Therefore, these findings support the view that Fz4-FEVR is not prevented to 
exit from the ER and that is quickly recycled back by a retrogade vesicular 
traffic operating not further than the intermediate compartment. Most likely, 
the tight localization in the ER shown at 37°C would be the result of retention 
and reclying, and further work is needed to evaluate the contribution of these 
two mechanisms in Fz4-FEVR localization. 
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Fig.16: Accumulation of chimeric VSVG-Fz4-FEVR tail at the ERES as 
revealed by incubation 10°C and colocalization with Sec-31. 
A) Huh-7 cells, transiently transfected with indicated constructs were incubated for 
16hrs at non-permessive temperature of 40°C and precessed for immunofluorescence 
analysis before or after incubation for 2hrs at the temperature of 10°C or 15°C. B) The 
histogram shows the persent of colocalization with Sec-31 protein, marker of ERES. 
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Fig.17: Absence of accumulation of chimeric VSVG-Fz4-FEVR tail at the 
ERGIC as revealed by incubation 15°C and colocalization with ERGIC-
53. 
A) Huh-7 cells, transiently transfected with indicated constructs were incubated for 
16hrs at non-permessive temperature of 40°C and precessed for immunofluorescence 
analysis before or after incubation for 2hrs at the temperature of 10°C or 15°C. B) The 
histogram shows the persent of colocalization with ERGIC-53 protein, marker of 
ERGIC. 
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Fig.18: Accumulation full lenght of Fz4-FEVR at ERES and ERGIC as 
revealed by incubation 10°C and 15°C and colobeling with Sec-31 and 
ERGIC-53 proteins. 
A,B) Huh-7 cells, transiently transfected with indicated constructs, incubated for 48hrs 
at 37°C and fixed and processed for immunoflourescence microscopy before or after 
an 2hrs of incubation at 10°C or 15°C. The persentage of colocalization is shown on 
the right. 
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2.4.6 Alpha Crystallin B-chain is a new interactor of Fz4 and its 
mutant Fz4-FEVR. 
 
In order to idenfy specifics interactors for the mutant receptor Fz4-FEVR, 
HEK293T cells were transiently transfected with cDNAs encoding for N-
terminal HA-tagged Fz4 or Fz4-FEVR and after 48hrs, detergent-lysed and 
immunoprecipitated mouse monoclonal anti-HA antibody. 
The immunoprecipitaed proteins were resolved by SDS-PAGE and analyzed 
by mass spectrometry. This approch gave a number of potential interactor 
proteins. Among them was alpha crystallin B-chain (CRYAB). It belongs to 
the small hit shock family protein (sHSP), it is a major lens protein but it is 
also expressed in numerous non-lens tissues of vertebrates, consistently with its 
chaperone function (Bhat SP et al. 1989; Sax CM, Piatigorsky J. 1994; Van 
Noort JM et al. 1995; Renkawek K et al. 1999; Arrigo AP. 1995). Patients 
who carry a missense mutation in αB-crystallin (R120G) develop desmin-
related myopathy and cataracts (Vicart P., et al. 1998). It is likely that 
maintaining genomic integrity is important in the lens since the anterior lens 
epithelial cells are held in the G0 phase of the cell cycle throughout life 
(Reddan JR. 1982; Gao CY et al. 1999). One study suggested that αB-
crystallin may be an important component of the cellular machinery involved 
in maintaining genomic stability (Andley UP et al. 2001). The reduced thermal 
stability and the dominant negative effects of the mutant αB-crystallin may be 
the direct cause of cataract because αB-crystallin null mice have clear lenses 
(Brady JP et al. 2001). α-Crystallins, especially CRYAB, are expressed in 
several other tissues under stress conditions. α-Crystallin A-chain appears to 
function as a molecular chaperone in prevention of stress-induced precipitation 
of β- and λ-crystallins (Dawson DW et al. 1999). Being a small heat shock 
protein, CRYAB can be constitutively expressed and increased in response to 
cellular stresses (Samali A, Orrenius S. 1998). 
In order to investigate whether CRYAB specifically interacts with Fz4-FEVR, 
we transiently transfected HEK293T wih cDNAs encoding for N-terminal 
3xFLAG-tagged CRYAB (Fig.S3.D1) , and N-terminal HA-tagged Fz4, Fz4-
FEVR or Fz4-tail less (Fz4-Δ35) (Fig.19B) (Fig.S3.A3). After 48hrs the cells 
were lysated, the proteins were immunoprecipitated with a rabbit polyclonal 
anti-HA antibody and the co-immoprecipitated proteins were detected by 
western blot with a mouse monoclonal anti-FLAG antibody. As it is shown in 
Fig.19B and C, CRYAB was co-immunoprecipitated by both wild-type and 
mutant receptor. In addiction, CRYAB was co-immunoprecipitated also by 
Fz4-tail less, suggesting that it interacts with the cytosolic loops of Fz4.  
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Fig.19: CRYAB interacts with Fz4 receptor in tail independent manner. 
A,B) HEK293T cells were co-transfected with indicated constructs for 48hrs. The 
lysates were immunoprecipitated and revealed by western blot after SDS-gel. The 
content of relevant protein experiment in which the Fz4 receptor were 
immunoprecipitated by a rabbit anti-HA antibody while the co-immunoprecipitated 
CRYAB was detected by a mouse anti-FLAG muose. Fz4 receptor used for the 
experiment are denscribed in B. 
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2.4.7 The overexpression of CRYAB promotes the cell surface 
expression of Fz4-FEVR. 
 
In order to investigate the functional role of CRYAB on Fz4 and Fz4-FEVR, 
Huh-7 cells were transiently transfected wih 3xFLAG-CRYAB, HA-Fz4 or 
HA-Fz4-FEVR expression vectors. After 48hrs, the cells were fixed and the 
intracellular localization of the proteins was analyzed by indirect 
immunofluorescence. Preliminary results showed that the overexpression of 
CRYAB does not influence the localization of Fz4 receptor; in contrast, the 
localization of Fz4-FEVR drastically changed, as shown by an intracellular 
labeling much more similar to Fz4 and by the possible expression on the cell 
surface (data not shown). This result suggested the intriguing hypothesis that 
CRYAB overexpression could rescue cell surface expression of Fz4-FEVR. To 
check and to quantify this effect, Huh-7 cells were transiently transfected with 
HA-Fz4 and HA-Fz4-FEVR alone or together 3xFLAG-CRYAB, and analyzed 
for surface and intracellular labeling. Interestingly, as shown in Fig.20, 
CRYAB overexpression promotes a strong recovery of cell surface expression 
of Fz4-FEVR (about 50% of Fz4, either expressed alone or with CRYAB). In 
contrast, the recovery of Fz4-FEVR on plasma membrane was much less 
efficient when co-transfected with the mutant CRYAB (R120G) (Fig.S3.D2), 
defective for its chaperone activity (Joseph Horwitz 2002; Ste´phanie Simon 
et al. 2007). This result strongly indicates that the chaperone activity of 
CRYAB is able to overcome the tight mechanism of retention of Fz4-FEVR in 
the ER. 
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Fig.20: CRYAB over-expression promotes cell surface expression of Fz4-
FEVR. 
Huh-7 cells were transfected with the indicated construts for 48hrs and processed for 
triple indirect imunofluorescence microscopy as denscribed in materials and methods 
section. The percent of cell surface expression was evalueted and is shown on the 
right. 
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2.4.8 CRYAB over-expression reverts the dominant negative 
effect of Fz4-FEVR on cell surface expression of Fz4. 
 
Based on the evidence that CRYAB over-expression rescues cell surface 
expression of Fz4-FEVR, we asked whether this over-expression can inhibit 
the dominant negative effect of Fz4-FEVR on cell surface expression of Fz4. 
First of all, we reproduced the dominant effect in COS-7 cells transiently 
transfected with Fz4 and Fz4-FEVR at a 1 to 5 ratio, respectivly (Kaykas A. et 
al. 2004). As shown in Fig.21A, Fz4 receptor expressed alone is mostly located 
on cell surface while the co-expression with Fz4-FEVR results in its tight 
localization in the ER, colocalizing with Fz4-FEVR and calnexin (Fig.21B). 
More intriguingly, CRYAB overexpression results on the relocalization of Fz4 
on the cell surface, preventing its trapping in the ER (Fig.21A); but, 
apparently, it does not rescues anymore Fz4-FEVR expression on the cell 
surface (Fig.21A). In addiction, we observed that the intracellular staining of 
Fz4, Fz4-FEVR and calnexin changes in the cells expressing the dominance 
negative phenotype (Fig.21A and B). further work is needed to explain these 
apparent discrepancies. Howerver, the most important outcome of the results 
shown in Fig.20 and 21 is that CRYAB may represent an important target to 
develope a therapeutical approach to target the dominant form of FEVR 
determined by Fz4-FEVR. 
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Fig.21: CRYAB overexpression reverts the dominant negative effect of 
Fz4-FEVR on Fz4. 
A) COS-7 cells were transiently transfected with myc-tagged Fz4, HA-Fz4-FEVR, 
3xFlag-CRYAB or its mutant 3xFlag-CRAYB(R120G) as indicated. 48 hours post-
transfection the cells were fixed and processed for immunofluorescence microscopy. 
B) Colocalization of myc-Fz4 transfected in COS-7 cells and the endogenous 
Calnexin protein, in the the presence or in the absence of cotransfected 3xFlag-
CRAYB. Cells were manipulated as in A. 
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Fig.S3: Schematic representation of the constructs used. 
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2.5 CONCLUSION. 
 
In the present work we characterized the mutant receptor Frizzled4 
(L501fsX533) associated to the dominant form of famialial exudative 
vitreoretinopathy. As previously described the mutant Fz4-FEVR is not 
expressed on the plasma membrane of transfected cells but is retained in the 
endoplasmatic reticulum where it traps the wild-type counterpart by 
oligomerization (Johane Robitaille et al. 2002; Kaykas A. et al. 2004). Our 
data shed much light on the intracellular localization of the mutant receptor. At 
the steady state, Fz4-FEVR shows an almost exclusive ER localization by 
confocal immunofluorescence microscopy, as evidenciated by a complete 
colocalization with calnexin. More importantly, this localization is most likely 
mediated by specific protein(s) interacting with its new cytosolic tail, as 
indicated by the acquired ER localization of VSVG-Fz4-FEVR tail constructs 
and by the rescue of cell surface expression of Fz4-FEVR in the presence of 
competing Fz4-FEVR tail expressed as a cytosolic peptide. Finally, 
temperature shift experiments performed on chimeric constructs or Fz4 and 
Fz4-FEVR indicates that an efficient recycling mecchanism most likely 
contributes to the ER localization of Fz4-FEVR. 
Interenstingly, the ER localization of Fz4-FEVR triggers its oligomerization. 
Indeed, velocity gradients show that Fz4 wild-type, that was mostly located on 
the plasma membrane, is almost exlusively in monomeric forms at steady state, 
while Fz4-FEVR, that is tightly located in the ER at steady state, forms mainly 
oligomers. However, newly synthesized Fz4 and Fz4-FEVR shows a similar 
level of oligomerization, about 50% suggesting that monomeric Fz4 forms do 
exit from the ER, while monomeric Fz4-FEVR are impaired to exit the ER and 
form with time more and more oligomeric forms that would contribute to the 
ER localization. Noteworthy, oligomerization in the ER is the crucial step 
required for the export of many transmembrane receptors or channels (Tao 
Y.X. et al. 2004, Thomas R.M. et al. 2007, Guan R. et al. 2009, Guan R. et al. 
2010), but it can determine ER retention of others (Shamie Das et al. 2009). 
In addiction, we have identified CRYAB as an interactor of both Fz4 and 
Fz4-FEVR. Alpha-Crystallins, the major eye lens protein, belong to small heat 
shock protein (sHSP) family, due to structural and functional similarities 
(Klemenz R. et al. 1991; Crabbe M.J.C. et al. 2001). Alpha-Crystallins consist 
of alphaA and alphaB subunits of 20 kDa each and exists as a polydisperse 
oligomer with an average molecular mass of 600-800 kDa (Groenen P.J.T.A. 
et al. 1999). More recently, alpha-Crystallins have been shown to be present in 
a number of non-lenticular tissues, suggesting that they may have a more 
general cellular function. Like all other sHSP, alpha-Crystallins act as a 
molecular chaperone by preventing the aggregation of proteins denatured by 
heat or other stress conditions (Horwitz J. et al 1992; Horwitz J. et al. 1998). 
Although, the mechanism of chaperone function of alpha-Crystallins is not 
fully understood, it was shown that they specifically recognize aggregation-
prone, non-native structures that occur early on the denaturation pathway of 
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protein. Numerous studies have shown that the chaperone activity of alpha-
Crystallins is dependent on the presence of surface-exposed hydrophobic 
patches (Raman B. et al.1994; Das K.P. et al. 1995; Sharma, K.K. et al.1998).  
Interestigly, the interaction between Fz4 and CRYAB does not depend on the 
presence of both wild-type or mutant tail of the receptor, suggesting that the 
recognition is mediated by the cytosolic loops of the receptor. CRYAB over-
expression does not influence the subcellular distribution of Fz4 in transfected 
cell and we have no clues at the moment on the functional relevance of this 
interaction; in contrast, it significantly influences the localization of Fz4-
FEVR, as evidenced by the difference intracellular distribution and the 
abundant recovery of the mutant receptor on cell surface. According to the 
previous results exstensively described in literature on its chaperone activity 
(G. Bhanuprakash Reddy et al. 2002), CRYAB prevents or resolves the 
aggregation of several cytosolic proteins. For this reason, we think that the 
recovery to the cell surface of Fz4-FEVR may be due to the chaperone activity 
of CRYAB that would inhibit the oligomerization of the mutant receptor, thus 
allowing its export from the ER and localization on plasma membrane. In 
support of this conclusion is the finding that a mutated CRYAB, devoid of 
chaperone activity, has very minor effect on Fz4-FEVR intracellular transport. 
At the best of our knowledge, this is the first evidence that CRYAB acts as a 
chaperone for transmembrane proteins. Moreover, and mostly importantly, 
CRYAB over-expression reverted the dominant negative effect of Fz4-FEVR 
on Fz4 previosly described in literature (Kaykas A. et al. 2004). Our results 
indicate that CRYAB is able to free Fz4 receptor from the oligomer formed 
with Fz4-FEVR, promoting its export and delivery to the plasma membrane. 
Further work is required to verify that the Fz4 forms that have reached the cell 
surface in these condition are able to elicit signal transduction in response to 
Norrin. Moreover, it will be interesting to investigate whether CRYAB may act 
as chaperone on other mutated transmembrane receptors that are retained in the 
ER. Indeed, a number of mutated receptors act as dominat negative on their 
wild-type counterparts impairing their ER export (Tao Y.X. et al. 2004, 
Thomas R.M. et al. 2007, Guan R. et al. 2009, Guan R. et al. 2010).  
In conclusion, the most interesting outcome of this work is the possibility that 
CRYAB may open new therapeutic approches for the autosomal dominant 
form of familial exudative vitreoretinopathy. 
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Summary
E3 ubiquitin ligases give specificity to the ubiquitylation process by selectively binding substrates. Recently, their function has emerged
as a crucial modulator of T-cell tolerance and immunity. However, substrates, partners and mechanism of action for most E3 ligases
remain largely unknown. In this study, we identified the human T-cell co-receptor CD8 a-chain as binding partner of the ligand of Numb
proteins X1 (LNX1p80 isoform) and X2 (LNX2). Both LNX mRNAs were found expressed in T cells purified from human blood, and
both proteins interacted with CD8a in human HPB-ALL T cells. By using an in vitro assay and a heterologous expression system we
showed that the interaction is mediated by the PDZ (PSD95-DlgA-ZO-1) domains of LNX proteins and the cytosolic C-terminal valine
motif of CD8a. Moreover, CD8a redistributed LNX1 or LNX2 from the cytosol to the plasma membrane, whereas, remarkably, LNX1
or LNX2 promoted CD8a ubiquitylation, downregulation from the plasma membrane, transport to the lysosomes, and degradation. Our
findings highlight the function of LNX proteins as E3 ligases and suggest a mechanism of regulation for CD8a localization at the plasma
membrane by ubiquitylation and endocytosis.
Key words: CD8, E3 ligase, LNX protein, Endocytosis, Ubiquitylation
Introduction
The localization of transmembrane receptors at the plasma membrane
(PM) is dynamically controlled by both the rate of delivery via the
exocytic pathway and the rate of internalization and transport to the
endosomes via endocytosis. Intrinsic protein-sorting signals and
cellular machineries able to decode them regulate traffic along the
two routes. Alteration in these mechanisms affects proper receptor
function at the PM and is often correlated to pathologies (reviewed in
Benado et al., 2009; Mellman and Nelson, 2008; Stenmark, 2009).
One of the sorting signals for proteins along the exo- and
endocytic pathways is the ubiquitylation, a post-translational
modification by which ubiquitin, a polypeptide of 76 amino acid
residues, is covalently attached to lysine (Lys) residues of a
substrate protein (Hershko and Ciechanover, 1992). Once thought
to only mediate proteasomal degradation in the cytosol (Pickart
and Fushman, 2004), ubiquitylation might also occur at the PM
where it regulates protein internalization, at the trans-Golgi
complex where it directs proteins to the late endosomes, and in
endosomes to sort proteins to the multivesicular bodies (reviewed
in Mukhopadhyay and Riezman, 2007; Piper and Luzio, 2007). In
all these cases, it results in protein degradation into the
lysosomes. The fate and the transport of the tagged substrate
will depend on the Lys residue involved in the formation of
ubiquitylation chains, as well as on the number of residues added.
Single ubiquitin monomers can be attached to one or several Lys
of a protein (mono- or multimonoubiquitylation, respectively).
Ubiquitin itself possesses several Lys residues that can be used
for the attachment of another ubiquitin molecule, allowing
substrates to be modified with different types of ubiquitin chains
(polyubiquitylation). Ubiquitylation occurs in a stepwise manner
involving three enzymes: an ubiquitin-activating enzyme E1 is
responsible for the attachment of free ubiquitin; a second
ubiquitin-conjugating enzyme E2 receives it from E1; and a
third ubiquitin ligase E3 catalyzes the final transfer of the
ubiquitin from the E2 enzyme to the substrate. The specificity of
the ubiquitylation process is determined by the E3 ligases, which
are suggested to function as an adaptor to bind substrates
selectively. More than 600 E3 ligases were found in the human
proteome and were classified into two major groups, defined by
the presence of either a HECT (homologous to the E6 associated
protein C terminus) or a RING (really interesting new gene)
domain as catalytic domain.
Recently, it has been emerging that E3 ligases play an
important function in regulating T-cell tolerance and immunity
(reviewed in Bhoj and Chen, 2009; Deshaies and Joazeiro, 2009;
Gomez-Martin et al., 2008). For instance, the E3 ligase c-Cbl
regulates T-cell receptor (TCR) activation by both degrading key
signalling molecules such as PLCc-1 (Jeon et al., 2004) and
controlling TCR internalization and transport to the lysosomes
(Naramura et al., 2002). Interestingly, the defective expression of
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some E3 ligases has been related to the development of
autoimmune diseases, such as encephalomyelitis, arthritis and
autoimmune diabetes (Chiang et al., 2000; Gronski et al., 2004;
Jeon et al., 2004). However, to date, our knowledge of the
substrates, partners, biological functions and mechanism of
action for most E3 ligases remains elusive.
The T-cell co-receptor CD8 is a type I transmembrane protein
expressed as aa homodimer on the surface of intestinal T cells, cd T
cells, thymic T-cell precursors and NK cells, and as ab heterodimer
on thymocytes and peripheral T cells (Gangadharan and Cheroutre,
2004; Irie et al., 1995). The surface expression of CD8ab heterodimer
depends on the a-chain (Goldrath et al., 1997). Efficient surface
expression of the a-chain requires its cytosolic C-terminal valine
motif (C-TVM), a ligand of PDZ domains that modulate its delivery
to the PM by sequentially interacting with GRASP65 and GRASP55
proteins (D’Angelo et al., 2009; Iodice et al., 2001). Required for the
activation of cytotoxic T lymphocytes, CD8 stabilizes the interaction
between the TCR on the surface of the lymphocytes and the class
I major histocompatibility complex on antigen-presenting cells.
Furthermore, it recruits the p56lck protein tyrosine kinase, bound to
the cytosolic tail of its a-chain, to the vicinity of the TCR. As such,
CD8 functions as coactivator, because Lck is a major proximal
effector of the T cell activation cascade (Salmond et al., 2009; Weiss
and Littman, 1994). Development of cytotoxic T lymphocytes was
greatly reduced in mice lacking CD8a (Fung-Leung et al., 1991), and
defects in CD8a and CD8b expression were shown to correlate with
pathological conditions such as immunodeficiencies and Wiskott-
Aldrich syndrome (de la Calle-Martin et al., 2001; Kawabata et al.,
1996; Schmitz et al., 1998). How CD8 function is regulated at the PM
and whether and how its impairment leads to immune diseases is still
largely unknown.
In this study, we were looking for proteins that could modulate
CD8a localization at the PM by using CD8a cytosolic tail as bait in
a two-hybrid assay. We identified and characterized the interactions
between CD8a and LNX1p80 and LNX2, which result in
CD8a ubiquitylation, internalization in the endocytic pathway and
degradation. We also demonstrated that LNX proteins are expressed
in the same physiological context as CD8a and interact with it in
human HPB-ALL T cells. Thus, our data strongly suggest that the
E3 ubiquitin ligase activity of both LNX proteins is involved in the
regulation of CD8a localization at the PM.
Results
CD8a binds the LNX proteins LNX2 and LNX1p80
In order to identify novel interacting-proteins involved in the
regulation of CD8a intracellular trafficking, we performed a
yeast two-hybrid screening using a human liver cDNA library
and the CD8a cytosolic C-terminal tail as bait (Fig. 1A). Among
Fig. 1. Identification and characterization of LNX2 and LNX1p80 as interacting partners of CD8a. (A) Amino acid sequences of CD8a wild-type and DYV
mutant cytosolic C-terminal tail used as baits in the two-hybrid assay. The + symbol indicates lysine residues where ubiquitin chains might be attached.
(B) Identification of the N-terminal fragment of LNX2 by two-hybrid assay: the yeast colony expressing the N-terminal fragment was able to grow on a high-
stringency selection plate when co-transformed with plasmid expressing the CD8a wild-type cytosolic tail. No growth was detected when either a control plasmid
(pGBKT7, vector with the GAL4 DNA binding domain) or a plasmid expressing the DYV-mutated tail was co-transformed. CNTR represents yeast colony
transfected with the vector expressing only the GAL4 activation domain, which grew at low extent in all the transformations. (C) Representation of LNX2 and
LNX1p80. LNX proteins contain a RING finger domain, an NPAY or NPAF motif for interaction with Numb protein and four PDZ domains. The line underneath
LNX2 indicates the fragment obtained by two-hybrid assay. (D) In vitro interaction between either LNX2 or LNX1p80 and the cytosolic tail of CD8a.
Glutathione-Sepharose beads, loaded with GST fused to CD8a wild-type (lanes 2 and 5) or DYV mutant cytosolic tail (lanes 3 and 6), were incubated with LNX2
(lanes 2 and 3) or LNX1p80 (lanes 5 and 6) that had been labelled with [35S]methionine and translated in vitro. Bound proteins were eluted from the beads and
analyzed together with the loaded samples (L, lanes 1 and 4) by SDS-PAGE and autoradiography. Numbers on the left indicate the molecular mass (kDa).
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positive clones, one contained a cDNA fragment encoding amino
acids 56–451 of the LNX2 protein (Fig. 1B). LNX2 was initially
identified as a ligand of the endocytic protein Numb (ligand of
Numb protein X) (Dho et al., 1998; Rice et al., 2001). It was
classified as a RING-type E3 ligase because it contains an N-
terminal RING finger domain (Fig. 1C). However, it has been
poorly characterized and its function as E3 ligase has never been
addressed. In addition, it also contains four PDZ domains,
presumably mediating protein–protein interactions. The cDNA
fragment identified by the two-hybrid assay corresponded to the
LNX2 N-terminal region including the RING finger domain, the
NPAY motif for the interaction with Numb, and the first two
PDZ domains (Fig. 1C). Interestingly, the interaction was
disrupted when the PDZ ligand signal was removed from the
bait by deletion of the terminal Tyr and Val residues from the C-
TVM (CD8-DYV) (Fig. 1B), indicating that the binding between
CD8a and LNX2 is strongly dependent on this signal.
To confirm the interaction between LNX2 and CD8a, LNX2
cDNA was transcribed in vitro and translated. The radioactively
labelled protein was incubated with either the CD8a cytosolic
C-terminal tail or its DYV-mutant fused to GST (see Materials
and Methods). The bound proteins were separated by SDS-PAGE
and revealed by autoradiography. As shown in Fig. 1D, LNX2
associates in vitro with the cytosolic C-terminal tail of CD8a
(Fig. 1D, lane 2), but not with its DYV mutant (Fig. 1D, lane 3).
LNX2 is closely related to the p80 isoform of LNX1, another
member of the LNX protein family (Fig. 1C) (Dho et al., 1998;
Rice et al., 2001). However, in contrast to LNX2, the function of
LNX1p80 as E3 ligase has been partially explored (Kansaku
et al., 2006; Takahashi et al., 2009). For these reasons, we
decided to test whether LNX1 is also a CD8a binding protein. On
the other hand, we were not surprised that this protein was not
found in our two-hybrid assay because LNX1p80 is poorly
expressed in human liver cells (Dho et al., 1998). As observed for
LNX2, in vitro transcribed and translated LNX1p80 was also able
to interact with the CD8a cytosolic C-terminal tail fused to GST
(Fig. 1D, lane 5). The removal of the C-TVM from CD8a
decreased the interaction (Fig. 1D, lane 6).
CD8a protein is usually present in T and NK cells, but whether
LNX1p80 or LNX2 is expressed in the same cell type has never
been described. Therefore, we purified a T- and NK-cell-enriched
fraction from human blood (see Materials and Methods) and
performed RT-PCR by using primers specific for mRNAs
encoding LNX1p80 and LNX2. Both genes were efficiently
Fig. 2. In vivo interaction between CD8a and either
LNX2 or LNX1p80. (A) CD8a was
immunoprecipitated from human HPB-ALL T cells
lysates and visualized by immunoblotting. A control
experiment (CNTR) was also performed by using mouse
IgGs. Arrowheads point to CD8a, which was
immunoprecipitated with the mouse OKT-8 antibody
(lanes 2 and 4), but not with mouse IgGs (lane 6). The
presence of either LNX1p80 (lane 4) or LNX2 (lane 2)
in the immunoprecipitates was revealed with specific
antibodies. In the control, immunoblotting was
performed by concomitantly using anti-LNX1p80 and
anti-LNX2 antibodies (lane 6). Aliquots (100 mg) of
total proteins were precipitated and loaded (L).
However, CD8a and LNX proteins (lanes 1, 3 and 5)
were poorly detectable in these fractions. Asterisks
mark the immunoglobulin light chains revealed by
immunoblotting. (B) CD8a was expressed with GFP
(lane 1), GFP–LNX1p80 (lane 2) or GFP–LNX2 (lane
3) in HEK293 cells. After 24 hours of transfection,
LNX proteins were immunoprecipitated from cell
lysates by an anti-GFP antibody and visualized by
immunoblotting. The presence of CD8a in the
immunoprecipitates was revealed with anti-CD8a
antibody. Lysates were also analysed by
immunoblotting with anti-tubulin antibody as loading
control. (C) CD8a or CD8a-DYV was expressed alone
(lanes 2, 3, 6 and 7) or together with either GFP–LNX2
(lanes 1 and 4) or GFP–LNX1p80 (lanes 5 and 8) in
HEK293 cells. After 24 hours of transfection, CD8a
was immunoprecipitated from cell lysates and
visualized by immunoblotting. The presence of LNX
proteins in the precipitates was revealed with an anti-
LNX2 (lanes 1–4) or anti-GFP (lanes 5–8) antibody.
Numbers on the left indicate molecular mass (kDa).
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Fig. 3. CD8a expression leads to redistribution of
LNX1p80 or LNX2 to the PM. (A–P) GFP–
LNX1p80 (A–H; green,) or GFP–LNX2 (I–P; green,)
was expressed in HEK293 cells alone (A–B,I–J) or
together with either CD8a (C–E,K–M) or CD8-DYV
(F–H,N–P). After 24 hours of transfection, cells were
fixed and immunostained for CD8a (red). (E,H,M,P)
Merged images. Yellow arrowheads in K–M indicate
colocalization between CD8a and GFP–LNX2,
presumably at the Golgi complex. A single confocal
section is shown. Scale bars: 3 mm.
Journal of Cell Science 124 (0)4
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
expressed in these cells (supplementary material Fig. S1, lanes 2
and 3). Unfortunately, the low level of endogenous CD8a protein
did not allow us to co-immunoprecipitate LNX proteins from this
cell fraction. Therefore, we used the human HPB-ALL T-cell line
and demonstrated that, in these cells, LNX1p80 and LNX2 were
pulled down by CD8a (Fig. 2A, lanes 2 and 4). Therefore, these
data suggested that such interactions also occur in the
physiological context of the T-cell co-receptor CD8a.
In order to further characterize this interaction, we decided to
shift to a heterologous expression system that could be more
easily handled and allow higher level of protein expression.
Therefore, GFP and GFP-tagged versions of LNX1p80 and
LNX2 were generated, transfected with CD8a in HEK293 cells,
and then immunoprecipitated from cell lysates by an anti-GFP
antibody. The presence of CD8a in the precipitates was tested by
immunoblotting. Consistent with the previous data, GFP–
LNX1p80 (Fig. 2B, lane 2) and GFP–LNX2 (Fig. 2B, lane 3),
but not GFP (Fig. 2B, lane 1), were able to co-immunoprecipitate
CD8a. Likewise, CD8a pulled-down GFP–LNX2 (Fig. 2C, lane
1) and GFP–LNX1p80 (Fig. 2C, lane 5). In the absence of CD8a
C-TVM, LNX2 interaction was completely lost (Fig. 2C, lane 4),
whereas LNX1p80 interaction decreased (Fig. 2C, lane 8).
Therefore, CD8a in vitro and in vivo interacts with LNX2 and
LNX1p80 and these interactions require its C-TVM.
It has been previously shown that LNX1p80 interacts with the
junctional proteins JAM-4 via the second PDZ domain (Kansaku
et al., 2006), and that the first two PDZ domains of LNX2 are
required for binding to the cell surface coxsackievirus and
adenovirus receptor (CAR) (Sollerbrant et al., 2003). To identify
regions of LNX1p80 and LNX2 important for CD8a recognition,
we generated a series of truncation mutants containing separately
the distinct domains, and tested their ability to bind the CD8a
cytosolic C-terminal tail or its DYV mutant fused to the GST
(supplementary material Fig. S2). Consistent with the results
of the two-hybrid assay, the N-terminal fragment of LNX2
including the RING domain, NPAY signal and the first two PDZ
domains was able, although to a less extent, to interact with the
CD8a tail in a YV-dependent manner. However, neither the
RING domain nor the NPAY motif alone interacted in the same
way as the full-length protein. By contrast, we found that the
fragment including all four PDZ domains was indispensable for a
proper interaction with CD8a. Indeed, the in vitro binding
efficiency of the fragment was comparable to that observed for
the full-length protein (supplementary material Fig. S2).
Moreover, when expressed in HEK293 cells, it was co-
immunoprecipitated by CD8a (supplementary material Fig.
S3A, lane 3). Among the four PDZ domains of LNX2, the first
two appeared to have a major role because they were sufficient,
although to a lesser extent, to bind the CD8a tail in a YV-
dependent manner. Similar results were overall observed for the
LNX1p80 protein (supplementary material Figs S2 and S3A),
thus fully confirming the observation that LNX1p80 and LNX2
interact with CD8a via their four PDZ domains.
CD8a expression leads to redistribution of LNX1p80 or
LNX2 to the plasma membrane
To examine the intracellular localization of LNX1p80 and LNX2 in
mammalian cells, GFP- or haemagglutinin (HA)-tagged constructs
of the two proteins were generated and expressed in HEK293 cells.
GFP–LNX1p80 exhibited both a cytosolic and nuclear localization
(Fig. 3A), as previously described (Zheng et al., 2010). By contrast,
GFP–LNX2 was exclusively cytosolic (Fig. 3I). Remarkably, we
found that this localization was changed upon simultaneous
expression of wild-type CD8a: both GFP–LNX1p80 (Fig. 3C–E)
and GFP–LNX2 (Fig. 3K–M) appeared to redistribute at the PM,
where CD8a localized as well. In addition, GFP–LNX2 was also
recruited by CD8a at the Golgi complex (Fig. 3K–M, arrowheads).
Interestingly, HA-tagged fragments containing the four PDZ
domains of either LNX1p80 or LNX2 were also relocated at the
PM upon CD8a coexpression (supplementary material Fig. S3Ba–
c,Bg–i). Moreover, as expected, expression of the CD8-DYV did
not have any effect on the intracellular distribution of all these
chimeric proteins (Fig. 3F–H,N–P, and supplementary material
Fig. S3Bd–f,Bj–l). These results confirmed that CD8a interacts in
live cells with LNX1p80 and LNX2, strongly suggesting a
functional role of these interactions.
LNX1p80 and LNX2 promote ubiquitylation of CD8a
Next, we examined whether LNX1p80 was able to ubiquitylate
CD8a, as previously described for claudin (Takahashi et al.,
2009), and whether also LNX2 was endowed of ubiquitylation
activity. For this purpose, we coexpressed CD8a, HA-tagged
ubiquitin, and GFP, GFP–LNX1p80 or GFP–LNX2 in HEK293
cells (Fig. 4). After 24 hours of transfection, CD8a was
Fig. 4. LNX1p80- and LNX2-dependent ubiquitylation of CD8a. Plasmids
expressing CD8a, HA-tagged ubiquitin and GFP, GFP–LNX1p80 or GFP–
LNX2 were transiently co-transfected in HEK293 cells. After 24 hours, CD8a
was immunoprecipitated from cell lysates and the ubiquitylated CD8a
fraction (Ub-CD8) was revealed by immunoblotting with anti-HA antibody.
Total lysates were also analyzed by immunoblotting with anti-CD8a
antibody. GFP-tagged LNX proteins were immunoprecipitated from cell
lysates with a GFP monoclonal antibody followed by immunoblotting with an
anti-GFP polyclonal antibody. The asterisks indicate three ubiquitylated
CD8a bands, which might correspond to monoubiquitylation of single, double
and triple Lys residues. The parenthesis indicates the smear pattern and higher
molecular weight ubiquitylated CD8a forms detected only in the presence of
LNX2. Numbers on the left indicate molecular mass (kDa).
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immunoprecipitated from cell lysates and its level of
ubiquitylation was analyzed by immunoblotting with an anti-
HA antibody (Fig. 4). In contrast to the control (Fig. 4, lane 1), a
pattern of HA signal was found in the presence of the
coexpressed GFP–LNX1p80 (Fig. 4, lane 2) or GFP–LNX2
(Fig. 4, lane 3). Because the cytosolic tail of CD8a has three
Fig. 5. High expression of GFP–LNX1p80 and GFP–LNX2, but not GFP, induces CD8a downregulation from the PM. (A–L) Huh-7 cells expressing, by
the new transfection procedure, CD8a and a high level of GFP (A–D), GFP–LNX1p80 (E–H) or GFP–LNX2 (I–L) were fixed and analyzed by indirect
immunofluorescence. (B,F,J) Cells stained for CD8a before permeabilization in order to label the CD8a fraction localized on the PM (CD8 ext; red). (C,G,K)
Cells stained for CD8a after permeabilization to label the CD8a intracellular fraction (CD8 int; blue). (D,H,L) Merged images. Expression of GFP (A; green),
GFP–LNX1p80 (E; green) or GFP–LNX2 (I; green) are shown. A single confocal section is shown. Histogram shows the ratio between the external and the
internal CD8a fraction quantified for the three distinct co-transfections, as described in Materials and Methods. Scale bars: 3 mm.
Journal of Cell Science 124 (0)6
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
potential Lys residues for ubiquitylation (Fig. 1A), the lower
three bands visualized by the anti-HA antibody (Fig. 4, asterisks)
might correspond to monoubiquitylation of single, double and
triple Lys residues. Higher bands, possibly corresponding to
polyubiquitylated forms, and a smear pattern were detected
exclusively when CD8a was coexpressed with LNX2 (Fig. 4,
lane 3). These results clearly indicated that both LNX1p80 and
LNX2 induce CD8a ubiquitylation.
LNX1p80 and LNX2 control CD8a localization at the
plasma membrane
While performing the immunofluorescence experiments on
HEK293 cells, we observed a reduction in CD8a levels at the
PM, which correlated with higher levels of LNX protein
expression (data not shown). In order to verify and clearly
visualize this effect, we decided to shift to the human hepatoma
cell line Huh-7, because these cells are bigger and more spread
than HEK293 cells, allowing a better visualization of protein
localization at the PM. Moreover, we changed our transfection
procedure by initially transfecting cells with GFP–LNX1p80,
GFP–LNX2 or GFP and, only 24 hours later, with CD8a. This
allowed us to accumulate high level of LNX proteins in cells
before CD8a expression. Then, after a further 24 hours, cells
were fixed and, before detergent permeabilization, directly
treated with an anti-CD8 polyclonal antibody to uniquely label
the CD8a fraction localized at the PM. Cells were then
permeabilized and the CD8a intracellular fraction was revealed
by using an anti-CD8 monoclonal antibody. As shown in Fig. 5,
Fig. 6. High expression of GFP–LNX1p80 and GFP–LNX2, but not GFP, promotes CD8a transport to the early endosomes. (A–L) Huh-7 cells expressing,
by the new transfection procedure, CD8a and a high level of GFP (A–D), GFP–LNX1p80 (E–H) or GFP–LNX2 (I–L) were fixed and stained for CD8a (B,F,J;
red) and the early endosomes marker EEA1 (C,G,K; blue). (D,H,L) Merge images. Higher magnification of the cell areas marked by yellow lines are shown
below. Arrowheads indicate endocytic structures where CD8a colocalizes with GFP–LNX1p80 or GFP–LNX2, but not GFP. Asterisks mark cells expressing only
CD8a. A single confocal section is shown. Scale bars: 3 mm.
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upon coexpression with either GFP–LNX1p80 (Fig. 5E–H) or
GFP–LNX2 (Fig. 5I–L), the amount of CD8a localized at the PM
was strongly decreased in comparison with cells expressing
CD8a alone (Fig. 5F,J) or together with GFP (Fig. 5A–D). We
quantified this decrease by measuring the ratio between the PM
and intracellular signal detected by immunofluorescence (for
quantification see Materials and Methods). As shown in Fig. 5,
with respect to the control coexpression of CD8a and GFP, only
,50% of CD8a at the PM was detected upon GFP–LNX1p80
or GFP–LNX2 coexpression. Therefore, we concluded that
LNX1p80 and LNX2 modulate CD8a protein levels at the PM.
LNX1p80 and LNX2 are involved in endocytic trafficking
and degradation of CD8a
The monoubiquitylation of CD8a and its downregulation from the
PM in the presence of LNX1p80 and LNX2 suggest that the two
LNX proteins are involved in CD8a internalization and degradation.
To address this hypothesis, Huh-7 cells expressing (by the new
transfection procedure) a high level of GFP–LNX1p80, GFP–LNX2
or GFP together with CD8awere examined by immunofluorescence
using antibodies specific for an early endosomes marker (EEA1)
and a lysosomal marker (LAMP1), aiming to detect accumulation of
CD8a into endocytic compartments. We found that in the presence
of either GFP–LNX1p80 (Fig. 6E–H; Fig. 7E–H) or GFP–LNX2
(Fig. 6I–L; Fig. 7I–L), concomitantly to its downregulation from
the PM, a fraction of CD8a accumulated in EEA1- or LAMP1-
positive compartments (Fig. 6E–L; Fig. 7E–L, arrowheads). By
contrast, in cells expressing only CD8a (Fig. 6F,J, asterisks) or
CD8a together with GFP (Fig. 6A–D; Fig. 7A–D), CD8a was not
significantly detected in endocytic structures and was mainly
visualized at the PM. Similar results were also observed in HEK293
cells (data not shown).
Fig. 7. High expression of GFP–LNX1p80 and GFP–LNX2, but not GFP, promotes CD8a transport to the lysosomes. (A–L) Huh-7 cells expressing, by the
new transfection procedure, CD8a and a high level of GFP (A–D), GFP–LNX1p80 (E–H) or GFP–LNX2 (I–L) were fixed and stained for CD8a (B,F,J; red) and the
lysosomal marker LAMP1 (C,G,K; blue). (D,H,L) Merged images. Higher magnification of the cell areas marked by yellow lines are shown below. Arrowheads
indicate endocytic structures where CD8a colocalizes with GFP–LNX1p80 or GFP–LNX2, but not GFP. A single confocal section is shown. Scale bars: 3 mm.
Journal of Cell Science 124 (0)8
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Next, we examined whether CD8a downregulation from the PM
observed by the new transfection procedure resulted in co-receptor
degradation. We have previously observed that simultaneous co-
transfection of CD8a and GFP–LNX proteins induced CD8a
ubiquitylation but did not decrease the total amount of CD8a in the
whole lysate (Fig. 4, lanes 1–3). By contrast, Fig. 8 clearly shows
that, on equal conditions of co-transfection efficiency and input
protein level (tubulin protein level), when GFP–LNX1p80 (Fig. 8,
lane 2) or GFP–LNX2 (Fig. 8, lane 3) are highly expressed, the
total amount of CD8a in the whole lysate was smaller than that of
GFP-coexpressing cells (Fig. 8, lane 1). Remarkably, such effect
on CD8a was not observed when CD8a was coexpressed with the
HA-tagged PDZ domains of either LNX1p80 or LNX2 (Fig. 8,
lanes 4 and 5), which bind CD8a (supplementary material Figs S2
and S3), but lack the RING domains. To understand whether this
degradation takes place in the lysosomes, we treated cells with the
lysosome inhibitor chloroquine (Fig. 8, lanes 6–10) and found that
the amount of CD8a in the whole lysate was significantly
increased by this treatment (Fig. 8, lanes 7 and 8). These data
strongly suggest that LNX1p80 and LNX2 induce CD8a transport
to the lysosomes and subsequent degradation.
Discussion
In this paper, we identify and characterize the interaction between
the human co-receptor CD8a and LNX1p80 and LNX2 proteins.
Our data show that this binding occurs in vitro and in vivo and
mutually affects the localization of each partner: CD8a recruits
LNX1p80 or LNX2 from the cytosol to the PM, whereas,
remarkably, LNX1p80 or LNX2 expression leads to CD8a
ubiquitylation, downregulation from the PM, endocytosis and
degradation.
RING-based E3 ligases confer specificity to ubiquitylation by
recognizing target substrates. Accordingly, they have been linked
to the control of many cellular processes and to multiple human
diseases. However, despite their relevance, the functional
characterization of most of them remains at a rudimentary stage
(Deshaies and Joazeiro, 2009). The activity of LNX1 as E3
ubiquitin ligase has been recently explored. Two splicing variants
of LNX1 exist, p70 and p80. The LNX1p70 binds the junctional
protein JAM4, and its overexpression facilitates JAM4 endocytosis
(Kansaku et al., 2006). On the other hand, LNX1p80 is an
interacting partner of claudin-1 and promotes its ubiquitylation,
removal from the tight junctions and transport to the lysosomes
(Takahashi et al., 2009). Interestingly, LNX1 downregulation
has been associated to gliomas (Chen et al., 2005) and to the
cardiovascular Kawasaki infectious disease (Burgner et al., 2009),
indicating its indispensable relevance for the proper functionality
of distinct tissues and organs. In contrast to LNX1, LNX2 has been
poorly studied and the only interacting protein so far identified was
the cell surface coxsackievirus and adenovirus receptor (CAR)
Fig. 8. Lysosomal degradation of CD8a protein in cells highly expressing either GFP–LNX1p80 or GFP–LNX2. HEK293 cells expressing, by the new
transfection procedure, CD8a and a high level of GFP (lanes 1 and 6), GFP–LNX1p80 (lanes 2 and 7), GFP–LNX2 (lanes 3 and 8), HA-tagged PDZ1–PDZ4
domains of LNX1p80 (lanes 4 and 9) or LNX2 (lanes 5 and 10), were cultured with or without chloroquine treatment. After cell lysis, CD8a protein was
immunoprecipitated from equal cell lysate aliquots and revealed by immunoblotting. In parallel, equal cell lysate aliquots were used to reveal GFP and GFP-
tagged LNX proteins with an anti-GFP monoclonal antibody, and HA-tagged PDZ domains of LNX1p80 and LNX2 with an anti-HA monoclonal antibody.
Lysates were also analyzed by immunoblotting with anti-tubulin antibody as loading control. Numbers on the left indicate molecular mass (kDa).
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(Mirza et al., 2006). No information is available to date on whether
LNX2 behaves, similarly to LNX1, as an E3 ubiquitin ligase in
mammalian cells. Here, we shed much light on the function of both
LNX proteins: we demonstrate that they are expressed in human T
lymphocytes and we identify an important novel partner for them,
the human TCR co-receptor CD8a. This finding suggests that
LNX proteins play a role in the regulation of T-cell tolerance and
immunity, similarly to the E3 ligase c-Cbl, which also has a RING
finger domain (Jeon et al., 2004; Naramura et al., 2002). Future
work will test this interesting hypothesis.
Although the anterograde transport of CD8a and b chains
along the exocytic pathway has been described (D’Angelo et al.,
2009; Erra et al., 1999; Goldrath et al., 1997; Pascale et al.,
1992), whether and how CD8 localization at PM is regulated by
endocytic trafficking and which signals and cellular machineries
are involved are so far largely unknown. The identification of the
LNX ubiquitin ligases as interacting proteins of CD8a, their
redistribution at the PM upon CD8a expression, and the effect of
LNX protein expression on CD8a localization and expression can
help answer these questions and help in understanding how
impairment of CD8 function and localization at the PM might
lead to immune diseases. It will also be interesting to investigate
whether and how LNX proteins regulate the localization of the
CD8 ab heterodimer.
Despite the strong similarity between LNX1p80 and LNX2
structure and function, potentially interesting differences might
distinguish them. In contrast to LNX1p80, LNX2 is recruited by
CD8a also to the Golgi complex; its interaction is more severely
dependent on the C-TVM of CD8a, and LNX2 expression also
induces a smear pattern of ubiquitylation, which might correspond
to CD8a polyubiquitylated forms. Intriguingly, although mono- or
multimonoubiquitylation has been notably involved in endocytosis
(Mukhopadhyay and Riezman, 2007), polyubiquitylation has also
been associated with direct sorting from the Golgi to the vacuole of
the yeast protein Gap1 (Soetens et al., 2001). Therefore, LNX2
might be also involved in the regulation of CD8a transport to,
through, or from the Golgi complex, which has already been
shown to be strongly dependent on the C-TVM of the co-receptor
(D’Angelo et al., 2009). Further work is required to verify this
hypothesis.
In conclusion, our results identify two major interacting
partners of the human co-receptor CD8a, providing the first
link between the possible regulation of the function of CD8a at
the PM of lymphocytes and ubiquitylation, endocytosis and
lysosomal degradation.
Materials and Methods
Reagents
All of the culture reagents were obtained from Sigma-Aldrich (Milan, Italy). The
solid chemical and liquid reagents were obtained from E. Merck (Darmstadt,
Germany), Farmitalia Carlo Erba (Milan, Italy), Serva Feinbiochemica
(Heidelberg, Germany), Delchimica (Naples, Italy) and BDH (Poole, United
Kingdom). The radiochemicals were obtained from Perkin Elmer (Bruxelles,
Belgium). Protein A-Sepharose CL-4B and the enhanced chemiluminescence
reagents were from Amersham Biosciences (Milan, Italy).
Antibodies
The following antibodies were used: the OKT8 mouse anti-CD8a monoclonal
antibody from Ortho (Raritan, NJ); the N1 mouse anti-CD8a monoclonal antibody
and rabbit anti-CD8a polyclonal antibody from M. Jackson (Martire et al., 1996);
rabbit anti-LNX1 antibody (Kansaku et al., 2006); rabbit and mouse anti-GFP and
anti-HA antibodies (Santa Cruz Biotechnology); mouse anti-EEA1 monoclonal
antibody (BD Transduction Laboratories, Lexington, KY); mouse anti- CD7107a
(LAMP1) monoclonal antibody (Biolegend, San Diego, CA); peroxidase-
conjugated anti-mouse and anti-rabbit IgG (Sigma-Aldrich, Milan, Italy); and
Texas-Red-conjugated anti-mouse IgG and FITC-conjugated anti-rabbit IgG
(Jackson ImmunoResearch Laboratories, West Grove, PA).
Antibody production
A polyclonal antiserum against LNX2 was generated by immunizing rabbits with
GST fused to the first 50 amino acids of LNX2, which are specific for LNX2 and
not conserved in LNX1p80. The antibody was affinity-purified as described
(Nielsen et al., 2000) and its ability to recognize LNX2, but not LNX1p80, was
verified by western blot analysis of extracts from cells transfected either with
GFP–LNX1p80 or GFP–LNX2.
Yeast two-hybrid assay
In order to construct the bait vector, the cDNA fragment encoding the wild-type or
DTY mutant C-terminal tail of CD8a was amplified by PCR and subcloned in the
vector pGBKT7 (Clontech). The vector expressing the wild-type CD8a C-terminal
tail was used to screen a human liver cDNA library made in the pGAD10 vector
(Clontech) using the Saccharomyces cerevisiae strain AH109. The transformants
were plated on synthetic medium lacking histidine, leucine, and tryptophan. His+
colonies were transferred onto nitrocellulose filters and assayed for b-galactosidase
activity. His+ and lacZ+ colonies were indicative of positive interaction. cDNA
from positive clones was extracted, purified and sequenced. The recovered library
plasmids were then tested for interaction with CD8a tail by co-transformation with
the vectors pGBKT7, pGBKT7-CD8a or pGBKT7-CD8a2DTY in S. cerevisiae
strain AH109. To quantify the interactions, the b-galactosidase assay was again
used.
cDNA cloning and plasmid construction
The expression vector FLTRbT8 for wild-type CD8a and CD8a-DYV (Iodice
et al., 2001; Mottola et al., 2000) and HA-ubiquitin (Mauro et al., 2006) have been
previously described. cDNAs encoding LNX1p80 (ID 4995278) and LNX2
(ID 5541168) were obtained from I.M.A.G.E. Consortium. GFP–LNX1p80 and
GFP–LNX2 expression vectors were generated by PCR and subcloning of
LNX1p80 and LNX2 cDNAs in the pEGFP-N1 vector (Clontech).
For in vitro binding assays, GST fused to wild-type or DYV-mutant CD8a were
expressed using pGEX-6P-1 (Pharmacia Biotech.). LNX1p80, LNX2 and all their
truncated forms were subcloned in the expression vector pcDNA3 (Clontech). The
following LNX1p80 cDNA fragments were expressed for the in vitro binding
assay shown in supplementary material Fig. S1: RING-NPAF (1–760 bp); RING
(1–309 bp); NPAF (309–760 bp); PDZ(1–4) (760–2187 bp); PDZ(1–2) (760–
1415 bp); PDZ(3–4) (1480–2187 bp); PDZ(1) (760–1074 bp), PDZ(2) (1114–
1415 bp).
The following LNX2 cDNA fragments were expressed for the in vitro binding
assay shown in supplementary material Fig. S1: RING-NPAY (1–666 bp); RING
(1–340 bp); NPAY (510–666 bp); PDZ(1–4) (637–2073 bp); PDZ(1–2) (682–
1386 bp); PDZ(3–4) (1378–2073 bp); PDZ(1) (682–983 bp), PDZ(2) (961–
1386 bp).
In vitro binding assay
LNX1p80 or LNX2 proteins were translated in vitro and labelled with 35S-
methionine using the TnTR coupled reticulocyte lysate system (Promega). 10 ml of
the full-length LNX proteins or fragments were incubated with 30 ml of
glutathione-Sepharose beads loaded with GST or GST fused to wild-type or
DYV-mutant CD8a. Bound proteins were eluted from the beads and analysed by
SDS-PAGE and autoradiography. In all the GST-pull down experiments, the
loading control (L) represents 20% of the whole amount of in vitro translated
proteins used for incubation.
Cell culture, transfection and immunofluorescence
Human embryonal kidney HEK293 and human hepatoma Huh-7 cells were
routinely grown at 37 C˚ in Dulbecco’s modified essential medium (DMEM),
containing 10% foetal bovine serum (FBS). HPB-ALL T cells were cultured in
RPMI 1640, containing 15% FBS.
HEK293 and Huh-7 cells were transfected by using FuGene 6.0 (Roche)
according to the manufacturer’s instructions. The effect of CD8a expression on
LNX protein localization was obtained by simultaneous co-transfection of CD8a
and LNX protein expression vectors and, 24 hours later, cell fixation or lysis. To
observe the effect of LNX protein expression on CD8a localization and protein
level, cells were initially transfected with LNX protein expression vectors in order
to allow accumulation of LNX proteins and, 24 hours later, transfected a second
time with CD8a expression vectors. Then, after a further 24 hours, they were
either lysed or fixed.
Indirect immunofluorescence was performed as previously described (Mottola
et al., 2000). Single confocal images were acquired at 636 and 1006
magnification on a Meta Zeiss Confocal Microscope (Carl Zeiss, Jena, Germany).
To separately stain CD8a protein on either cell surface or intracellular
membranes, cells were incubated after fixation with the rabbit anti-CD8a
polyclonal antibody, then permeabilized and incubated with the mouse anti-CD8a
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monoclonal antibody (Mottola et al., 2000). Two distinct secondary antibodies allow
separately visualizing the two fractions. Then, in order to measure the ratio between
levels of PM and intracellular CD8a, the immunofluorescence intensity in the two
channels was measured by using Adobe Photoshop and NIH ImageJ Biophotonic
programs. For each co-transfection, 15 cells were considered for quantification. The
results are given as mean ¡ s.d.
Preparation of cell extracts, immunoprecipitation SDS-PAGE and
western immunoblotting
Cells were lysed with 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA pH
8.0, and 1% Triton X-100. For all the experiments on transfected HEK293, 66106
cells were lysed and used for each co-immunoprecipitation. For the experiment on
HPB-ALL cells, 1006106 cells were used for each co-immunoprecipitation.
Immunoprecipitation was performed by overnight incubation with OKT-8, a
conformation-sensitive antibody anti-CD8a, followed by addition of Protein A-
Sepharose beads (Pharmacia). The immunoprecipitated pellets were washed,
treated for SDS-PAGE and resolved on a 10% polyacrylamide gel. For each
experiment, aliquots of the lysate (100 mg total protein per aliquot) were also
precipitated with acetone and treated for SDS-PAGE. Next, proteins were
transferred to nitrocellulose filters, which were then incubated with primary
antibodies diluted in blocking buffer (5% non-fat dry milk, 0.1% Tween-20
in PBS), followed by peroxidase-conjugated secondary antibodies. For anti-
LNX1p80 and anti-LNX2 antibodies, western blot was performed in PBS
containing 1% BSA. After washing, bound antibodies were detected by
enhanced chemiluminescence (Amersham Biosciences).
CD8a degradation was detected by previously treating cells with or without
90 mM chloroquine for 16 hours.
Preparation of human T cells
Peripheral blood mononuclear cells were isolated from leukopacks (Etablissement
Franc¸ais du Sang) by Ficoll gradient (MSL, Eurobio). T and NK cells were then
isolated by removing monocytes with CD14+ columns as recommended by the
manufacturer (Miltenyi Biotec).
Real time RT-PCR
Real time reverse-transcription PCR was performed as previously described (Ben
Amara et al., 2010). Total RNA was extracted from the T-cell-enriched fraction
and reverse transcribed using the MMLV-RT kit according to the manufacturer’s
protocol (Invitrogen). Forward and reverse primers were designed with the free
web software Primer3.
The following primers were used: For human LNX1: forward 59-GG-
AATTACCACGGTGCTTGTAT-39, reverse 59-TGTATGCTGGTGTTCCTTC-
AAC-39; expected PCR fragment length, 154 bp. For human LNX2: forward 59-
TCTTCATAAACGGGACTCTGGT-39, reverse 59-GCTGCTATGATTTCCTGC-
TTCT-39; expected PCR fragment length 291 bp. For human b-actin: forward 59-
GGAAATCGTGCGTGACATTA-39, reverse 59-AGGAAGGAAGGCTGGAAG-
AG-39; expected PCR fragment length: 309 bp.
Real time PCR was performed using the Applied Biosystem 7900HT Fast real-
time PCR system according to the manufacturer’s recommendations. The
experiments were performed in triplicate.
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